SHF Holdings, Inc. 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2026 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________to _________ Commission File Number 001-40524 SHF Holdings, Inc. (Exact name of registrant as specified in Its charter) Delaware 86-2409612 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) 1526 Cole Blvd. , Suite 250 Golden , Colorado 80401 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (303) 431-3435 (Former name or former address, if changed since last report) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Class A Common Stock, $0.0001 par value per share SHFS The Nasdaq Stock Market LLC Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $230 per share SHFSW The Nasdaq Stock Market LLC Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the registrant has submitted electronically, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging growth company ☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒ As of August 5, 2026, there were 12,332,955 shares of the Company’s Class A Common Stock, par value $ 0.0001 per share, outstanding. SHF HOLDINGS, INC. TABLE OF CONTENTS Page PART I – FINANCIAL INFORMATION: F-1 Item 1. Financial Statements (unaudited): F-1 Condensed Consolidated Balance Sheets as of June 30, 2026 and December 31, 2025 F-1 Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2026 and June 30, 2025 F-2 Condensed Consolidated Statements of Stockholders’ Equity (Deficit) for the three and six months ended June 30, 2026 and June 30, 2025 F-3 Condensed Consolidated Statement of Cash Flows for the six months ended June 30, 2026 and June 30, 2025 F-5 Notes to Unaudited Condensed Consolidated Financial Statements F-6 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 6 Item 3. Quantitative and Qualitative Disclosures About Market Risk 16 Item 4. Controls and Procedures 16 PART II - OTHER INFORMATION: 18 Item 1. Legal Proceedings 18 Item 1A. Risk Factors 18 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 18 Item 3. Defaults Upon Senior Securities 18 Item 4. Mine Safety Disclosures 18 Item 5. Other Information 18 Item 6. Exhibits 19 2 OTHER INFORMATION Unless the context otherwise indicates, when used in this Quarterly Report on Form 10-Q (this “Form 10-Q”), the terms “SHF Holdings,” “Safe Harbor,” “we,” “us,” “our,” the “Company” and similar terms refer to SHF Holdings, Inc., a Delaware corporation, and its wholly-owned subsidiaries, SHF, LLC, SHFxAbaca, LLC, Safe Harbor Retirement Services, LLC and SHF Managed Services, LLC. CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS Various of the statements made in this Form 10-Q, including information incorporated herein by reference to other documents, are “forward-looking statements” within the meaning of, and subject to the protections of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, assumptions, estimates, intentions and future performance and condition, and involve known and unknown risks, uncertainties and other factors, which may be beyond our control, and which may cause the actual results, performance, achievements, or financial condition of the Company to be materially different from future results, performance, achievements, or financial condition expressed or implied by such forward-looking statements. Furthermore, this Form 10-Q may contain forward-looking statements regarding the potential for federal rescheduling of cannabis, the potential passage of the SAFER Banking Act of 2025 (the “SAFER Banking Act”), projected growth of the cannabis market, the potential impact of regulatory changes on the Company’s business, the Reduction Periods (as defined below) and the anticipated benefits of the Second Amended and Restated Commercial Alliance (the “Second Amended CAA”). You should not expect us to update any forward-looking statements. These forward-looking statements should be read together with the discussion of the Company’s risks and uncertainties included under the caption “ Risk Factors ” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the Securities and Exchange Commission (“SEC”) on April 15, 2026. All statements other than statements of historical fact are statements that could be forward-looking statements. You can identify these forward-looking statements through our use of words such as “may,” “will,” “anticipate,” “assume,” “seek,” “should,” “indicate,” “would,” “believe,” “contemplate,” “consider,” “expect,” “estimate,” “continue,” “plan,” “point to,” “project,” “could,” “intend,” “target” and other similar words and expressions of the future. These forward-looking statements may not be realized due to a variety of factors, including, without limitation: 3 The foregoing factors should not be construed as exhaustive and should be read together with the other cautionary statements included in this Form 10-Q. Because of these risks and other uncertainties, our actual future financial condition, results, performance or achievements, or industry results, may be materially different from the results indicated by the forward-looking statements in this Form 10-Q. In addition, our past results of operations are not necessarily indicative of our future results of operations. You should not rely on any forward-looking statements as predictions of future events. All written or oral forward-looking statements that are made by us or are attributable to us are expressly qualified in their entirety by this cautionary note. Any forward-looking statement speaks only as of the date on which it is made, and we do not undertake any obligation to update, revise or correct any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law. ● Our profitability is subject to interest rate risk; ● Volatility and uncertainty in the financial markets and banking industry may adversely impact our clients and our ability to obtain additional financial institution customers; ● Liquidity risks could affect our operations and jeopardize our financial condition and certain funding sources could increase our interest rate expense; ● The industry in which our clients operate is considered federally illegal, which may pose risk if actions were taken against those clients or our Company; ● Our strategic plan and growth strategy may not be achieved as quickly or as fully as we seek; ● Our success depends on our ability to compete effectively in highly competitive markets; ● Potential gaps in our risk management policies may leave us exposed to unidentified or unanticipated risk, which could negatively affect our business; ● Our ability to resolve our material weaknesses in internal controls over financial reporting; ● We have identified and we may identify additional deficiencies in our internal controls, which may have an impact on our business operations; ● Technological changes affect our business including potentially impacting the revenue stream of traditional products and services, and we may have fewer resources than many competitors to invest in technological improvements; ● Our information systems may experience interruptions and security breaches, and are exposed to cybersecurity threats; ● Many of our major systems depend on and are operated by third-party vendors, and any systems failures or interruptions could adversely affect our operations and the services we provide to our clients; ● Our primary financial institution partner, Partner Colorado Credit Union (“PCCU”), is subject to certain regulations and regulatory capital requirements that could limit deposit growth and loan capacity; 4 ● Any failure to protect the confidentiality of customer information could adversely affect our reputation and subject us to financial sanctions and other costs that could have a material adverse effect on our business, financial condition and results of operations; ● Future acquisitions and expansion activities may disrupt our business, dilute shareholder value and adversely affect our operating results; ● We may not be able to generate sufficient cash to service all of our operation needs; ● Our business may be adversely affected by economic conditions in general and by conditions in the financial markets; ● We are subject to extensive regulations that could limit or restrict our activities and adversely affect our earnings; ● Litigation and regulatory investigations are increasingly common in our businesses and may result in significant financial losses and/or harm to our reputation; ● Liquidity risks arising from the uncertainty surrounding cash flows; ● We are subject to capital adequacy and Nasdaq Stock Market (“Nasdaq”) liquidity standards, and if we fail to meet these standards, whether due to losses, growth opportunities or an inability to raise additional capital or otherwise, our financial condition and results of operations would be adversely affected; ● The Company’s ability to comply with Nasdaq’s listing requirements and maintain its listing on Nasdaq is uncertain and subject to various risks and factors that may cause actual results to differ materially; ● Certain of our existing stockholders could exert significant control over the Company; ● If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, the price of our Class A Common Stock (“Common Stock”) and its trading volume could decline; ● We have the ability to issue additional equity securities, which would lead to dilution of our issued and outstanding Common Stock; ● We are an “emerging growth company,” and, as a result of the reduced disclosure and governance requirements applicable to emerging growth companies, our Common Stock may be less attractive to investors; ● We may be unable to attract and retain key people to support our business; ● In certain circumstances, we assume the risk of fraud loss and negative balances for accounts maintained at our financial institution partners; ● Severe weather, natural disasters, global pandemics, acts of war or terrorism, theft, civil unrest, government expropriation or other external events could have significant effects on our business; ● There is substantial doubt about our ability to continue as a going concern; and ● Other factors and information in other filings that we make with the SEC under the Exchange Act and Securities Act. 5 PART I – FINANCIAL INFORMATION SHF Holdings, Inc. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) June 30, 2026 December 31, 2025 ASSETS Current Assets: Cash and cash equivalents $ 5,729,576 $ 6,779,040 Accounts receivable – trade 21,010 31,376 Accounts receivable – related party 683,887 1,009,483 Accounts receivable 683,887 1,009,483 Prepaid expenses 532,632 862,400 Contract asset 516,283 516,283 Other current assets 3,454,688 3,000,000 Total Current Assets 10,938,076 12,198,582 Operating lease right to use asset 469,017 547,186 Investment in preferred securities - 1,450,000 Prepaid expenses 233,783 414,329 Contract asset 2,323,273 2,581,417 Other assets 189,155 15,510 Total Assets $ 14,153,304 $ 17,207,024 LIABILITIES AND STOCKHOLDERS’ EQUITY Current Liabilities: Accounts payable $ 530,398 $ 189,828 Accounts payable-related party 158,725 171,365 Accounts payable 158,725 171,365 Accrued expenses 824,169 1,310,463 Deferred revenue - 15,415 Operating lease liability 189,902 181,963 Deferred consideration 3,000,000 3,000,000 Stand-ready guarantee liability 711,670 711,667 Financial indemnification liability 232,516 433,968 Other current liabilities 562,388 485,055 Total Current Liabilities 6,209,768 6,499,724 Stand-ready guarantee liability 889,468 1,245,416 Financial indemnification liability 512,506 657,804 Operating lease liability 432,172 528,552 Warrant liabilities 8,423 39,620 Total Liabilities $ 8,052,337 $ 8,971,116 Commitments and Contingencies (Note 16) - Stockholders’ Equity Convertible preferred stock, $ .0001 par value, 1,250,000 shares authorized, 111 issued and outstanding on June 30, 2026, and December 31, 2025, respectively - - Series B Convertible Preferred Stock, $ .0001 par value,  35,000 shares authorized, 27,134 and 30,808 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively 3 3 Convertible preferred stock, value 3 3 Class A Common Stock, $ .0001 par value, 1,000,000,000 shares authorized, 12,332,955 and 4,281,523 issued and outstanding on June 30, 2026, and December 31, 2025, respectively 1,233 428 Additional paid-in capital 132,308,726 131,152,020 Accumulated deficit ( 126,208,995 ) ( 122,916,543 ) Total Stockholders’ Equity $ 6,100,967 $ 8,235,908 Total Liabilities and Stockholders’ Equity $ 14,153,304 $ 17,207,024 See accompanying notes to unaudited condensed consolidated financial statements. F- 1 SHF Holdings, Inc. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) 2026 2025 2026 2025 Three Months Ended June 30, Six Months Ended June 30, 2026 2025 2026 2025 Revenue $ 1,934,740 $ 1,845,334 $ 3,910,179 $ 3,777,686 Operating Expenses: Compensation and employee benefits 1,477,615 1,583,051 3,138,273 2,955,532 Professional services 792,804 712,337 1,938,613 2,211,871 Rent expense 60,971 63,185 112,403 124,191 Amortization of contract asset 129,072 - 258,144 - Credit benefit ( 386,119 ) - ( 702,695 ) - General and administrative expenses 886,751 457,803 1,955,151 1,448,629 Total operating expenses 2,961,094 2,816,376 6,699,889 6,740,223 Operating loss ( 1,026,354 ) ( 971,042 ) ( 2,789,710 ) ( 2,962,537 ) Other (Expenses) Income: Change in fair value of warrant liabilities 14,598 138,158 31,197 1,254,240 Change in fair value of deferred consideration - ( 40,960 ) - 120,040 Net loss on disposal of securities ( 340,408 ) - ( 340,408 ) - Issuance cost from the sale of the ELOC ( 182,229 ) - ( 210,109 ) - Interest expense ( 2,290 ) ( 115,341 ) ( 6,870 ) ( 228,127 ) Interest income 23,448 - 23,448 - Total other (expenses) income ( 486,881 ) ( 18,143 ) ( 502,742 ) 1,146,153 Net loss before income tax ( 1,513,235 ) ( 989,185 ) ( 3,292,452 ) ( 1,816,384 ) Income tax benefit - 58,470 - 58,470 Net loss ( 1,513,235 ) ( 930,715 ) ( 3,292,452 ) ( 1,757,914 ) Deemed dividends ( 981,146 ) - ( 1,068,758 ) - Net loss attributable to common stockholders $ ( 2,494,381 ) $ ( 930,715 ) $ ( 4,361,210 ) $ ( 1,757,914 ) Weighted average shares outstanding, basic and diluted 6,928,023 2,826,468 5,647,674 2,806,841 Basic and diluted net loss per share $ ( 0.36 ) $ ( 0.33 ) $ ( 0.77 ) $ ( 0.63 ) See accompanying notes to unaudited condensed consolidated financial statements. F- 2 SHF Holdings, Inc. Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) FOR THE THREE MONTHS ENDED JUNE 30, 2026 Shares Amount Shares Amount Shares Amount Capital Deficit Deficit Preferred Stock Convertible Preferred Stock Series B Class A Common Stock Additional Paid-in Accumulated Total Stockholders’ Shares Amount Shares Amount Shares Amount Capital Deficit Equity Balance, March 31, 2026 111 $ - 30,808 $ 3 4,505,485 $ 451 $ 131,420,587 $ ( 124,695,760 ) $ 6,725,281 Stock compensation expense - - - - - - 41,523 - 41,523 Sales of Class A Common Stock - - - - 2,907,462 290 1,139,637 - 1,139,927 Amortization of share-based consulting services - - - - - - 31,624 - 31,624 Forfeiture of Series B Convertible Preferred Stock - - ( 476 ) - - - ( 72,148 ) - ( 72,148 ) Conversion of Series B Convertible Preferred Stock - - ( 3,198 ) - 4,920,008 492 ( 492 ) - - Redemption of Series B Convertible Preferred Stock - - - - - - ( 252,005 ) - ( 252,005 ) Net loss - - - - - - - ( 1,513,235 ) ( 1,513,235 ) Balance, June 30, 2026 111 $ - 27,134 $ 3 12,332,955 $ 1,233 $ 132,308,726 $ ( 126,208,995 ) $ 6,100,967 FOR THE THREE MONTHS ENDED JUNE 30, 2025 Shares Amount Shares Amount Capital Deficit Deficit Preferred Stock Class A Common Stock Additional Paid-in Accumulated Total Stockholders’ Shares Amount Shares Amount Capital Deficit Deficit Balance, March 31, 2025 111 $ - 2,786,538 $ 278 $ 104,633,059 $ ( 121,582,744 ) $ ( 16,949,407 ) Issuance of shares resulting from reverse stock split - - 39,930 4 ( 4 ) - - Stock compensation expense - - - - 20,951 - 20,951 Net loss - - - - ( 930,715 ) ( 930,715 ) Balance, June 30, 2025 111 $ - 2,826,468 $ 282 $ 104,654,006 $ ( 122,513,459 ) $ ( 17,859,171 ) See accompanying notes to unaudited condensed consolidated financial statements. F- 3 SHF Holdings, Inc. Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) FOR THE SIX MONTHS ENDED JUNE 30, 2026 Shares Amount Shares Amount Shares Amount Capital Deficit Equity Preferred Stock Convertible Preferred Stock Series B Class A Common Stock Additional Paid-in Accumulated Total Stockholders’ Shares Amount Shares Amount Shares Amount Capital Deficit Equity Balance, December 31, 2025 111 - 30,808 $ 3 4,281,523 $ 428 $ 131,152,020 $ ( 122,916,543 ) $ 8,235,908 Stock compensation expense - - - - - - 100,431 - 100,431 Sales of Class A Common Stock - - - - 3,131,424 313 1,339,564 - 1,339,877 Amortization of share-based consulting services - - - - - - 84,374 - 84,374 Forfeiture of Series B Convertible Preferred Stock - - ( 476 ) - - - ( 72,148 ) - ( 72,148 ) Conversion of Series B Convertible Preferred Stock - - ( 3,198 ) - 4,920,008 492 ( 492 ) - - Redemption of Series B Convertible Preferred Stock - - - - - - ( 295,023 ) - ( 295,023 ) Net loss - - - - - - - ( 3,292,452 ) ( 3,292,452 ) Balance, June 30, 2026 111 27,134 $ 3 12,332,955 $ 1,233 $ 132,308,726 $ ( 126,208,995 ) $ 6,100,967 FOR THE SIX MONTHS ENDED JUNE 30, 2025 Shares Amount Shares Amount Capital Deficit Deficit Preferred Stock Class A Common Stock Additional Paid-in Accumulated Total Stockholders’ Shares Amount Shares Amount Capital Deficit Deficit Balance, December 31, 2024 111 $ - 2,783,667 $ 278 $ 108,467,253 $ ( 120,755,545 ) $ ( 12,288,014 ) Balance 111 $ - 2,783,667 $ 278 $ 108,467,253 $ ( 120,755,545 ) $ ( 12,288,014 ) Issuance of shares resulting from reverse stock split - - 39,930 4 ( 4 ) - - Issuance of restricted stock - 4,292 - 8,768 - 8,768 Stock withheld for net share settlement - ( 1,421 ) - - - Stock compensation expense - - 762,210 - 762,210 Reclassification of forward purchase receivable - - - - ( 4,584,221 ) - ( 4,584,221 ) Net loss - - - - - ( 1,757,914 ) ( 1,757,914 ) Balance, June 30, 2025 111 $ - 2,826,468 $ 282 $ 104,654,006 $ ( 122,513,459 ) $ ( 17,859,171 ) Balance 111 $ - 2,826,468 $ 282 $ 104,654,006 $ ( 122,513,459 ) $ ( 17,859,171 ) F- 4 SHF Holdings, Inc. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) 2026 2025 Six Months Ended June 30, 2026 2025 CASH FLOWS FROM OPERATING ACTIVITIES: Net loss $ ( 3,292,452 ) $ ( 1,757,914 ) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation expense - 2,518 Net loss on disposal of securities 340,408 - Amortization of contract asset 258,144 - Amortization of prepaid consulting (Series B Preferred Stock) 84,374 - Issuance cost from the sale of the ELOC 210,109 - Stock compensation expense 100,431 783,762 Lease expense ( 10,272 ) ( 2,172 ) Change in the fair value of deferred consideration - ( 120,040 ) Credit benefit ( 702,695 ) - Change in fair value of warrant ( 31,197 ) ( 1,254,240 ) Changes in operating assets and liabilities: Accounts receivable – trade 10,366 83,674 Accounts receivable – related party 325,596 385,168 Prepaid expenses 438,166 317,545 Accrued interest receivable - 14,214 Other assets ( 173,645 ) ( 286,672 ) Other current liabilities ( 217,690 ) ( 58,370 ) Accounts payable 340,570 486,818 Accounts payable – related party ( 12,640 ) 89,309 Accrued expenses ( 486,294 ) ( 480,811 ) Contract liabilities - ( 18,127 ) Deferred revenue ( 15,415 ) - Net cash used in operating activities ( 2,834,136 ) ( 1,815,338 ) CASH FLOWS FROM INVESTING ACTIVITIES: Proceeds from sale and redemption of preferred securities 654,904 - Net proceeds from loan repayment - 6,545 Net cash provided by investing activities 654,904 6,545 CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from the sale of Class A common stock 1,129,768 - Repayment of senior secured promissory note - ( 255,765 ) Net share settlement for stock compensation expense - ( 12,771 ) Net cash provided by (used in) financing activities 1,129,768 ( 268,536 ) Net decrease in cash and cash equivalents ( 1,049,464 ) ( 2,077,329 ) Cash and cash equivalents – beginning of period 6,779,040 2,324,647 Cash and cash equivalents – end of period $ 5,729,576 $ 247,318 Supplemental Disclosure of Non-Cash Investing and Financing Activities Reclassification of forward purchase receivable $ - ( 4,584,221 ) Receivable for unsettled ADTX sale $ 454,688 - Forfeiture of Series B shares related to consulting contract $ 72,148 - Accrued redemption payable to Series B holders $ 295,022 $ - Supplemental Disclosure of Cash Flows Information Interest paid $ 6,870 $ 228,901 See accompanying notes to unaudited condensed consolidated financial statements. F- 5 SHF Holdings, Inc. Notes to Unaudited Condensed Consolidated Financial Statements Note 1. Organization and Business Operations Business Description SHF Holdings, Inc. (the “Company” or “SHF”) is a Delaware corporation headquartered in Golden, Colorado, whose Class A Common Stock (“Common Stock”) is listed on the Nasdaq Capital Market (“Nasdaq”) under the ticker symbol “SHFS.” The Company was founded in 2015 by Partner Colorado Credit Union (“PCCU”) and was among the first financial services companies to provide compliant banking and lending services to cannabis related businesses (“CRBs”). SHF’s mission is to provide reliable and compliant financial services to the legal cannabis, hemp, and related industries by enabling its financial institution (“FI”) customers to offer compliance-driven banking, lending, and other financial services to CRB clients. The Company operates a proprietary fintech platform across 41 states and territories in the United States. Through this platform, SHF enables its FI customers to compliantly offer the following banking-related services to CRBs: ● Business checking and savings accounts; ● Cash management accounts ● Savings and investment options ● Commercial lending ● Courier services (via third-party relationships) ● Remote deposit services ● Automated Clearing House payments and origination ● Wire payments. The Company’s platform benefits both CRBs and financial institutions by providing CRBs access to compliant banking and giving financial institutions access to increased, compliantly monitored deposits. The Company generates revenue through fee income, investment income, loan program income and safe harbor program income earned by providing these compliance and lending services to financial institutions serving the cannabis industry. Note 2. Basis of Presentation and Summary of Significant Accounting Policies Significant Accounting Policies The accompanying interim unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and results of operations included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC. Refer to Note 2 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, for a description of the Company’s significant accounting policies. The Company has included disclosures below regarding basis of presentation and other accounting policies that (i) are required to be disclosed quarterly, (ii) have material changes or (iii) the Company views as critical as of the date of this report. F- 6 Basis of Presentation The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP” or “GAAP”) for interim financial information and the rules and regulations of the SEC. The accompanying unaudited condensed consolidated financial statements contain all normal and recurring adjustments necessary to state fairly the consolidated financial condition, results of operations, statements of shareholders’ equity, and cash flows of the Company for the interim periods presented. Except as otherwise disclosed, all such adjustments consist only of those of a normal recurring nature. Operating results for the three and six months ended June 30, 2026 are not necessarily indicative of the results that may be expected for the current year ending December 31, 2026 or other interim periods. The condensed unaudited consolidated financial statements include the accounts of SHF Holdings, Inc. and its 100 % wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the rules and regulations of the SEC and the instructions to Form 10-Q. Liquidity and Going Concern Liquidity refers to our ability to meet anticipated cash demands, including servicing debt, funding operations, maintaining assets, and covering other routine business expenses. Our primary cash outflows include operating costs, and general business expenditures. The sources of our liquidity include the cash inflows generated from operational performance, the sale of Common Stock pursuant to the Equity Line of Credit (the “ELOC”), and the sale of our investment in preferred shares of Aditxt, Inc. (“ADTX”), a publicly traded company. As of June 30, 2026, the Company had no secured debt, cash and cash equivalents of $ 5.7 million, working capital of $ 4.7 million, and total stockholders’ equity of $ 6.1 million, which exceeds the minimum Nasdaq requirements. The Company has incurred recurring losses from operations and negative cash flows from operations, including an operating loss of $ 2.8 million and net cash used in operating activities of $ 2.8 million for the six months ended June 30, 2026, and an accumulated deficit of $ 126.2 million as of June 30, 2026. In addition, it is reasonably possible but not probable that a material adverse effect may result from the litigation matter discussed in Note 16, Commitments and Contingencies. These conditions, considered in the aggregate, raise substantial doubt about the Company’s ability to continue as a going concern. Management has developed and is implementing a series of measures intended to preserve liquidity and support the Company’s ability to meet its obligations during the look-forward period: ● Strengthened Revenue Profile: The Second Amended Commercial Alliance Agreement (“Second Amended CAA”) with PCCU, effective October 1, 2025, increased the Company’s share of loan program income from approximately 35 % to up to 65 % of the loan program income generated by PCCU’s CRB loan portfolio, improving the recurring revenue profile of the Company’s core business on a prospective basis. For the six months ended June 30, 2026, this change increased loan program income by approximately $ 0.6 million comparatively. In addition, the asset hosting fee structure transitioned from a flat rate to a tiered marginal rate schedule based on average daily deposit balances, with rates ranging from 0.50% on the first $25 million to 1.25% on balances above $125 million, resulting in estimated annual savings of approximately $0.3 million compared to the rates contained in the First Amended CAA. The Company is also exploring strategic relationships with additional financial institutions. ● Access to Additional Capital: On September 17, 2025, the Company entered into the ELOC with an institutional investor (the “ELOC Investor”), under which the Company may, at its sole discretion and subject to customary conditions, sell up to $ 150.0 million of newly issued shares of Common Stock to the investor party thereto. The ELOC expires on September 17, 2028. For the six months ended June 30, 2026, the Company raised $ 1.1 million from the use of the ELOC. The Company’s continued ability to access the ELOC is subject to a number of conditions, including the absence of any Material Adverse Effect (as defined on page F-27 in subsection “Equity Line of Credit and Related Series B Redemption Obligation”), and there can be no assurance that the Company will be able to draw the full amount of the commitment. See Note 15, Stockholders’ Equity . There is no assurance that the Company can use the ELOC due to the current stock price. ● Expense Management: The Company is making strategic investments in marketing, lending and system development. Management has identified specific actionable cost reductions that are within its direct operational control and that it would implement should operating conditions deteriorate below base-case expectations, including pausing or restructuring said strategic investments. ● Cash Flow Monitoring: Management maintains a 52-week rolling cash flow projection that tracks anticipated expenses, revenues, and ending cash balances against budget. Cash positions are reviewed on a bi-weekly basis to ensure the Company maintains adequate liquidity to fund operations. Notwithstanding the measures described above, the Company continues to incur operating losses and negative cash flows from operations, and the Company’s ability to access the ELOC and to execute on its expense-management plans involves elements outside of management’s sole control. Accordingly, management has concluded that management’s plans, considered in the aggregate, do not alleviate the substantial doubt about the Company’s ability to continue as a going concern for a period of at least twelve months from the date these unaudited condensed consolidated financial statements are issued. The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets, or the amounts and classification of liabilities that might result from the outcome of this uncertainty. F- 7 Use of Estimates The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses and the disclosure of contingent assets and liabilities. Material estimates particularly subject to change in the near term include the Company’s financial indemnification liability, valuation allowance for deferred tax assets and the fair value of financial instruments including warrant liabilities. Actual results could differ from those estimates. Cash and Cash Equivalents Cash and cash equivalents consist of cash on hand, balances due from financial institutions, and other highly liquid investments with original maturities of three months or less from the date of purchase that are readily convertible to known amounts of cash and are subject to an insignificant risk of changes in value. As of June 30, 2026, cash and cash equivalents of $ 5.7 million consisted primarily of (i) approximately $ 4.6 million invested in a government money market fund and (ii) approximately $ 1.1 million held in operating accounts, substantially all of which was on deposit with Partner Colorado Credit Union (“PCCU”), a related party (see Note 9, Related Party Transactions.) The Company’s investment in a government money market fund represents operating cash of the Company’s wholly-owned subsidiary, SHF, LLC. Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”). Revenue is recognized when control of promised services is transferred to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those services, following the five-step model under ASC 606. ● Account Fee Income Account fee income consists of fees earned from cannabis-related businesses maintaining accounts with the Company’s financial institution partners, including deposit account fees, account activity fees, and onboarding income. These fees are recognized periodically in accordance with the fee schedules established with financial institution partners. Account fee income also includes merchant income earned through referral arrangements with third-party payment processors under which the Company receives a percentage of net revenue generated by referred merchants, recognized as earned. ● Investment Income Investment income represents the Company’s share of interest earned on net investable cannabis-related business deposit balances held at PCCU and is recognized monthly based on the average net daily deposit balance. Under the First Amended Commercial Alliance Agreement (“Amended CAA”), effective January 1, 2025, investment income was reduced by an investment hosting fee paid to PCCU. ● Loan Program Income Loan program income represents the Company’s allocated share of interest earned on cannabis-related business loans originated by PCCU. Under the Amended CAA, the Company’s share of loan program income was determined by a loan yield allocation formula that incorporated the Constant Maturity U.S. Treasury Rate published by the Federal Reserve, along with a proprietary risk rating formula to determine the allocation between the Company and PCCU. Under this formula, the Company received approximately 35 % of net interest income on applicable loans, with the remainder retained by PCCU. Effective October 1, 2025, the Second Amended CAA superseded the yield allocation formula and replaced it with a fixed split under which the Company receives up to 65 % of net interest income on applicable loans, with PCCU retaining the remaining 35 %. The fixed split is not subject to variation by risk rating or risk-based pricing methodology. If the Company determines that an adjustment to its indemnification obligation is required to maintain compliance with Nasdaq listing requirements, the Company’s share of loan program income will be adjusted by a corresponding amount on a go-forward basis for the applicable loans. ● Master Program Agreement Revenue The Company licenses its proprietary Safe Harbor Program to financial institutions under a Master Program Agreement, which grants a non-exclusive, non-transferable right to use the platform. Revenue under these agreements is recognized over the term of the arrangement as services are provided. Stock-Based Compensation The Company measures all equity-based payment arrangements to employees, directors, and non-employee consultants in accordance with ASC 718, Compensation - Stock Compensation. The grant-date fair value of stock-based awards is determined using either the quoted market price of the Company’s Common Stock or the Black-Scholes option valuation model, as appropriate for the instrument type. Compensation cost for service-based awards is recognized on a straight-line basis over the requisite service period. For performance-based awards, compensation cost is recognized when it becomes probable that the performance condition will be achieved. Forfeitures are recognized as they occur. F- 8 For non-employee awards settled in equity, including shares of the Company’s Series B Convertible Preferred Stock (the “Series B Convertible Preferred Stock”) and warrants issued to consultants, the Company measures the fair value at the grant date and recognizes the cost over the service period. Where awards are partially vested at issuance, the vested fair value is recorded as a prepaid asset and amortized to expense over the remaining service period. The Black-Scholes option model incorporates the following assumptions: expected term (using the simplified method as the average of contractual term and vesting period); expected stock price volatility (based on the Company’s historical stock price); risk-free interest rates (based on U.S. Treasury rates for maturities approximating expected lives); and expected dividend yield of zero (as the Company has not paid dividends and does not anticipate doing so in the foreseeable future). Changes in assumptions used to estimate fair value could result in materially different results. Warrant Liabilities and Derivative Instruments The Company evaluates all financial instruments, including warrants and conversion features, at issuance to determine whether they should be classified as equity or liabilities under ASC 815-40, Derivatives and Hedging - Contracts in an Entity’s Own Equity, and ASC 480, Distinguishing Liabilities from Equity. Warrants that do not meet the criteria for equity classification are recorded as liabilities at fair value on the date of issuance. These warrant liabilities are remeasured at fair value at each subsequent reporting date, with changes in fair value recognized in the consolidated statements of operations. Warrants are valued using the Black-Scholes-Merton model. Preferred Stock - Classification and Measurement The Company evaluates preferred stock instruments under ASC 480 and ASC 815-40 to determine the appropriate classification between liabilities, mezzanine equity, and permanent equity. Fair Value Measurements The Company utilizes the fair value hierarchy to apply fair value measurements. The fair value hierarchy is based on inputs to valuation techniques that are used to measure fair values that are either observable or unobservable. Observable inputs reflect assumptions market participants would use in pricing an asset or liability based on market data obtained from independent sources, while unobservable inputs reflect a reporting entity’s pricing based upon its own market assumptions. The basis for fair value measurements for each level within the hierarchy is described below: Level 1 : Quoted prices for identical assets or liabilities in active markets. Level 2 : Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; or model-derived valuations whose inputs are observable or whose significant value drivers are observable. Level 3 : Valuations derived from techniques in which one or more significant inputs are unobservable. F- 9 Segment Reporting The Company operates as one reportable segment, providing financial services and banking solutions to CRBs, under ASC 280, Segment Reporting. The chief operating decision maker, the Company’s Chief Executive Officer, reviews financial information on a consolidated basis when allocating resources and assessing performance. Financial Assets Measured at Amortized Cost For financial assets within the scope of ASC 326, the Company measures the allowance for credit losses based on relevant information about past events, current conditions, and reasonable and supportable forecasts of future economic conditions that can affect the collectability of the reported amounts. The allowance is deducted from the amortized cost basis of the financial asset on the unaudited condensed consolidated balance sheet, and the net amount represents management’s best estimate of the cash flows expected to be collected. Changes in the allowance for credit losses are recognized as credit loss expense or reversal in the unaudited condensed consolidated statements of operations. The Company considers the following factors, among others, in estimating expected credit losses: ● Historical loss experience and default rates for instruments with similar risk characteristics; ● The creditworthiness and financial condition of the counterparty; ● Current and forecasted macroeconomic conditions over the reasonable and supportable forecast period, reverting to historical averages beyond that period; and ● Collateral arrangements, recourse provisions, and other credit enhancements. Financial assets are written off against the allowance when management determines that the asset is uncollectible and all reasonable collection efforts have been exhausted. Subsequent recoveries, if any, are credited to the allowance for credit losses. Contract Asset The contract asset was recognized in connection with the Second Amended CAA within the scope of ASC 326. This asset represents costs incurred to fulfill the contract, specifically the cost of assuming the stand-ready guarantee obligation under ASC 460 and the contingent indemnification exposure under ASC 326. The contract asset is amortized on a systematic and rational basis over the contract term consistent with the release of the underlying guarantee exposure. The contract asset is evaluated for impairment under ASC 340-40-35-2 when facts and circumstances indicate the carrying amount may not be recoverable and any impairment identified is recognized in the period identified and may not be subsequently reversed. Stand Ready Guarantees – ASC 460 The Company accounts for financial guarantees in accordance with ASC 460, Guarantees. At the inception of a guarantee, the Company recognizes a liability equal to the fair value of the assumed stand-ready obligation. This non-contingent liability represents the value of the obligation undertaken by the Company to stand ready to perform under the guarantee, irrespective of the likelihood that a payment will actually be required. Subsequent to initial recognition, the stand-ready liability is amortized over the weighted average life of the guarantee, using a systematic approach that reflects the Company’s reduction in exposure to risk over time. If, at any reporting date, a contingent loss accrual required under ASC 450, Contingencies, exceeds the unamortized ASC 460 carrying amount, the Company records the higher contingent loss estimate in accordance with that guidance. F- 10 Financial Indemnification Liabilities Under ASC 326-20, the Company recognizes a financial indemnification liability for its indemnification obligation to PCCU under the Second Amended CAA. This liability represents the Company’s up to 65% share of the lifetime expected credit losses on the covered CRB loan portfolio, measured on a probability-weighted basis and updated each reporting period to reflect current conditions and reasonable and supportable forecasts of future economic conditions. The financial indemnification liability methodology considers historical loss experience, borrower-specific credit quality, collateral values, and forward-looking economic assumptions including conditions specific to the cannabis industry. The financial indemnification liability is measured independently from, and recognized in addition to, the ASC 460 stand-ready guarantee liability. The two liabilities coexist separately on the unaudited condensed consolidated balance sheet and do not offset or true up to each other. The ASC 460 liability is fixed at inception and released over the guarantee term, while the financial indemnification liability is dynamic and remeasured each quarter. Changes in the financial indemnification liability are recognized as credit loss expense or credit income in the unaudited condensed consolidated statements of operations in the period of remeasurement. Concentration of Risk The Company’s revenues are concentrated in the United States with a single customer, PCCU, which represented the substantial majority of revenue for the three and six months ended June 30, 2026 and June 30, 2025, see Note 9. Substantially all CRB client deposits are maintained at PCCU, and all fund transmissions to and from those deposit accounts are handled directly by PCCU. Financial instruments that potentially subject the Company to concentrations of credit risk consist of accounts receivable and cash accounts maintained at financial institutions. At times, account balances may exceed the Federal Deposit Insurance Corporation (“FDIC”) coverage limit of $ 0.25 million. As of June 30, 2026 and December 31, 2025, the Company had approximately $ 1.0 million and $ 6.5 million of account balances, respectively, in excess of FDIC coverage. Additionally, amounts due from PCCU represented approximately 97.0 % and 97.0 % of total accounts receivable as of June 30, 2026 and December 31, 2025, respectively, with balances of approximately $ 0.7 million and $ 1.0 million, respectively. The Company has not experienced losses on these accounts or receivables, and management does not believe the Company is exposed to significant credit risk on such accounts. Recently Issued Accounting Standards Standards Adopted in 2026 ASU 2024-04 – Debt - Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions: In November 2024, the Financial Accounting Standards Board (“FASB”) issued ASU 2024-04, which clarifies the accounting for induced conversions of convertible debt. The standard is effective for annual periods beginning after December 15, 2025. The Company adopted this standard prospectively. The adoption had no effect on the Company’s unaudited condensed consolidated financial statements, other than the recognition of a deemed dividend of $ 1.1 million for the three and six month periods ended June 30, 2026, as disclosed in Note 11. ASU 2025-05 - Financial Instruments - Credit Losses (Topic 326): Accounts Receivable and Contract Assets: In July 2025, the FASB issued ASU 2025-05, which provides a practical expedient by allowing entities to assume current credit conditions will remain unchanged for the remaining life of current accounts receivable and current contract assets under ASC 606. The standard is effective for years beginning after December 15, 2025. The Company adopted this standard prospectively and the adoption did not have an impact on its unaudited condensed consolidated financial statements. Standards Not Yet Adopted ASU 2024-03 / ASU 2025-01 - Disaggregation of Income Statement Expenses (Subtopic 220-40): In November 2024, the FASB issued ASU 2024-03, subsequently clarified by ASU 2025-01 (January 2025), requiring entities to disaggregate certain income statement expense line items in the footnotes, including purchases of inventory, employee compensation, depreciation, and amortization. The standard is effective for annual periods beginning after December 15, 2026, and interim periods within annual periods beginning after December 15, 2027. Early adoption is permitted. The Company plans to adopt this standard prospectively and does not anticipate a material impact on its financial reporting. ASU 2026-01 – Debt (Subtopic 505-10): Initial Measurement of Paid-in-Kind Dividends on Equity-Classified Preferred Stock: In April 2026, the FASB issued ASU 2026-01, which requires that paid-in-kind (“PIK”) dividends on equity-classified preferred stock be initially measured based on the PIK dividend rate stated in the preferred stock agreement for purposes of both financial statement recognition and earnings per share calculations. The standard does not change when PIK dividends are recorded or when they affect earnings per share. The standard is effective for annual periods beginning after December 15, 2026, and interim periods within those annual periods. Early adoption is permitted. F- 11 The Company will continue to monitor the development of accounting standards and intends to adopt them in accordance with their respective effective dates. Additional disclosures will be provided in future filings as the Company completes its assessment of these standards’ impact. Note 3 - Deferred Consideration On November 21, 2024, the Company deposited the $ 3.0 million second annual cash payment into the registry of the Denver County, Colorado District Court (the “District Court”) pending resolution of a dispute among former shareholders of Rockview Digital Solutions, Inc. (d/b/a Abaca) regarding the party authorized to receive the payment. See Note 16, Commitments and Contingencies. The change to deferred consideration resulted in an expense for the three months ended June 30, 2026 and June 30, 2025 was $ 0 and $ 0.04 million, respectively. The change to deferred consideration resulted in a credit for the six months ended June 30, 2026 and June 30, 2025 was $ 0 and $ 0.1 million, respectively. Deferred consideration as of June 30, 2026 and December 31, 2025 was $ 3.0 million. This amount has been deposited with the District Court registry, which is carried as a restricted asset pending resolution of the shareholder litigation described in Note 16, Commitments and Contingencies. Note 4 - Prepaid Expenses Prepaid expenses as of June 30, 2026 and December 31, 2025 consist of the following: Schedule of Prepaid Expenses As of June 30, 2026 As of December 31, 2025 Insurance $ 461,988 $ 791,423 Consulting 168,913 325,100 Others 135,514 160,206 Prepaid expenses 766,415 1,276,729 Less: Current portion 532,632 862,400 Total non-current portion $ 233,783 $ 414,329 Insurance The Company maintains several insurance policies. In addition, in connection with the Company’s de-SPAC transaction, the Company obtained a Directors and Officers liability run-off policy that provides coverage through September 2028. Consulting In connection with the September 30, 2025 recapitalization, the Company issued 1,063 shares of Series B Convertible Preferred Stock and Common Stock purchase warrants (as amended and restated, the “Series B Warrants”) to purchase 68,453 shares of Common Stock to three independent service providers in exchange for professional and marketing services to be rendered through September 30, 2027. The equity instruments were measured at their grant-date fair value of approximately $ 0.8 million based on a valuation performed by a third-party specialist and are classified within stockholders’ equity. The grant-date fair value was recorded as prepaid consulting and is being amortized to professional services expense on a straight-line basis over the two-year service period. Of these amounts, one of the three service providers received 480 shares of Series B Convertible Preferred Stock and a Series B Warrant to purchase up to 154,560 shares of Common Stock. Effective April 28, 2026, the Company and this service provider amended their agreement and, in connection therewith, the service provider returned to the Company 476 of the then-outstanding, unconverted shares of Series B Convertible Preferred Stock and its unexercised Series B Warrant to purchase up to 154,560 shares of Common Stock. The cancellation resulted in the reversal of a prepaid expense of $ 0.1 million, which is reflected in the unaudited condensed consolidated statement of Stockholders’ Equity for the three- and six-month periods ended June 30, 2026. Note 5 - Investment in Preferred Securities During the year ended December 31, 2025, in connection with the issuance of 1,875 shares of Series B Convertible Preferred Stock and accompanying Series B Warrants at $ 800 per share, the Company received, as non-cash consideration, preferred shares of ADTX. No cash was exchanged in this transaction. The ADTX preferred shares had an estimated fair value and carrying value of $ 1.5 million at the date of receipt. The investment represented less than 20% of the voting interests in ADTX, and the Company did not have the ability to exercise significant influence or control over ADTX . Accordingly, the investment was accounted for under ASC 321, Investments – Equity Securities. Because the ADTX preferred shares are not actively traded and lack a readily determinable fair value, the Company elected to measure the investment at cost, less any impairment, adjusted for observable price changes in orderly transactions for identical or similar instruments, as permitted under ASC 321-10-35-2. No impairments or other observable price changes were identified during the year ended December 31, 2025. During the year ended December 31, 2025, ADTX redeemed 43 shares of its preferred stock held by the Company, resulting in cash proceeds of approximately $ 0.05 million, all of which was collected during the period. No loss was recognized on this redemption. F- 12 During the six months ended June 30, 2026, ADTX redeemed approximately 23 shares of its preferred stock held by the Company in accordance with the terms of the preferred shares. These redemptions resulted in cash proceeds of approximately $ 0.03 million. During the three and six months ended June 30, 2026, the Company converted approximately 829 preferred ADTX shares into common shares and sold them for net proceeds of approximately $ 0.6 million. In addition, the Company sold approximately 606 preferred ADTX shares to an institutional investor for approximately $ 0.5 million. The combined proceeds totaled approximately $ 1.1 million, of which approximately $ 0.5 million remained receivable as of June 30, 2026, and is included in other current assets in the condensed unaudited consolidated balance sheet as of June 30, 2026. In connection with these redemptions and sales of shares, the Company recognized a loss of $ 0.3 million for the three and six months ended June 30, 2026 within the unaudited condensed consolidated statements of operations. The following table summarizes the activity in the investment during the six months ended June 30, 2026, and for the year ended December 31, 2025: Schedule of Activity in Investment Shares Amount Shares Amount As of June 30, 2026 December 31, 2025 Shares Amount Shares Amount Initial recognition at fair value (September 30, 2025) - - 1,500 $ 1,500,000 Beginning balance 1,457 $ 1,450,000 - - Proceeds from redemption ( 23 ) ( 25,017 ) ( 43 ) ( 50,000 ) Disposal of preferred securities ( 1,434 ) ( 1,084,575 ) - - Net loss on disposal of securities - ( 340,408 ) - - Ending balance - $ - 1,457 $ 1,450,000 Note 6 - Contract Asset The contract asset was recognized in connection with the Second Amended CAA within the scope of ASC 326. This asset represents costs incurred to fulfill the contract, specifically the cost of assuming the stand-ready guarantee obligation under ASC 460 and the contingent indemnification exposure under ASC 326. The contract asset is amortized on a systematic and rational basis over the contract term, consistent with the release of the underlying guarantee exposure. The contract asset is evaluated for impairment under ASC 340-40-35-2 when facts and circumstances indicate the carrying amount may not be recoverable, and any impairment identified is recognized in the period identified and may not be subsequently reversed. The following table summarizes the change in the contract asset for the three and six months ended June 30, 2026: Schedule of Contract Asset Stand-ready guarantee Financial indemnification Total Balance, December 31, 2025 $ 2,049,599 $ 1,048,101 $ 3,097,700 Amortization ( 85,401 ) ( 43,671 ) ( 129,072 ) Balance, March 31, 2026 1,964,198 1,004,430 2,968,628 Amortization ( 85,401 ) ( 43,671 ) ( 129,072 ) Balance, June 30, 2026 $ 1,878,797 $ 960,759 $ 2,839,556 As of June 30, 2026, $ 0.3 million and $ 0.2 million of the stand-ready guarantee and financial indemnification contract assets, respectively, are classified as current, with the remaining $ 1.5 million and $ 0.8 million classified as non-current. As of December 31, 2025, $ 0.3 million and $ 0.2 million of the stand-ready guarantee and financial indemnification contract assets, respectively, were classified as current, with the remaining $ 1.8 million and $ 0.9 million classified as non-current. Amortization of the contract asset was $ 0.1 million and $ 0.3 million for the three and six months ended June 30, 2026, respectively, compared to $ 0 for the three and six months ended June 30, 2025, representing the straight-line amortization of the cost to acquire the contract asset recognized as of October 1, 2025, the effective date of the Second Amended CAA. Amortization expense is recognized within operating expenses and is partially offset each period by the corresponding release of the stand-ready guarantee liability and remeasurement of the financial indemnification liability to income, as described in Note 7, Loan Portfolio Indemnification Obligations. Note 7 - Loan Portfolio Indemnification Obligations Under the Second Amended CAA, the Company indemnifies PCCU for up to 65% of default-related losses on PCCU’s CRB loan portfolio. The obligation is recognized as two independent, coexisting liabilities that do not offset each other: (i) a noncontingent stand-ready guarantee liability under ASC 460, measured at fair value at inception, and (ii) a contingent expected credit loss (benefit) liability under ASC 326-20, representing the Company’s up to 65% share of estimated lifetime expected credit losses (benefit) on the PCCU CRB portfolio. Each liability is recognized with a corresponding contract asset under ASC 340-40-25-2, as the indemnification costs are directly related to the Second Amended CAA and are expected to be recovered through the Company’s up to 65% share of loan program income. ASC 460 - Guarantee Liability The issuance of a guarantee imposes a noncontingent obligation to stand ready to perform and initial recognition is required at inception regardless of whether payment is probable. The stand-ready liability is recognized separately from the ASC 326 liability. F- 13 The stand-ready liability is measured at fair value at inception under ASC 820-10 using a market-based insurance pricing approach that is classified as Level 3 due to the absence of observable market inputs for cannabis lending guarantees. The fair value of a guarantee at inception reflects the premium that a market participant (analogized to a specialty insurance carrier) would charge in an arm’s-length transaction to underwrite the same risk. Because no direct market comparable exists for cannabis CRB loan portfolio guarantees, management estimated the standalone selling price by constructing the premium components a specialty financial guarantor would require. The fair value incorporates three components: (a) the expected loss element, representing the probability-weighted losses the guarantor expects to absorb; (b) a stand-ready risk premium, representing the additional compensation a market participant would require for uncertainty, volatility, and the uncapped nature of the commitment beyond expected losses; and (c) a time value adjustment. Key Level 3 inputs as of December 31, 2025 are as follows: Schedule of Significant Unobservable Input Significant Unobservable Input Pooled Probability of Default or PD (Ratings 2–5) 7.25 % Pooled Loss Given Default or LGD (inclusive of 16.6% cannabis qualitative premium) 35 % Tranche C PD 35 % Tranche C LGD on uncollateralized gap 50 % Stand-ready risk premium loading 120% of expected loss Discount rate 4.0 % Weighted average pay out year – Tranche A 4 years Weighted average pay out year – Tranche B 3 years Weighted average pay out year – Tranche C 2 years Weighted average pay out year – Stand Ready Premium 3 years For loans entered into subsequent to October 1, 2025, the effective date of the Second Amended CAA, management evaluates the stand-ready guarantee on a specific identification basis, separate from the pooled tranche inputs presented above. Loans originated under this methodology are evaluated using the tranche-specific assumptions determined at each loan’s origination date, as follows: Origination Quarter # Loans PD LGD (incl. cannabis qualitative premium) Stand-Ready Risk Premium Loading Discount Rate Weighted Avg Payout Three months ended June 30, 2026 2 7.25 % 25 % 120% of expected loss 4.4 % 5 years The maximum potential amount of future payments under the guarantee across all loans evaluated on a specific identification basis is approximately $ 33.4 million and $ 33.8 million as of June 30, 2026 and December 31, 2025, respectively, representing 65 % of the total outstanding CRB loan portfolio balance. The indemnification percentage is subject to reduction, at management’s discretion, under the Second Amended CAA’s listing-related adjustment clause. Each stand-ready guarantee liability tranche is reduced through amortization on a straight-line basis over its respective weighted average payout period, determined at origination and disclosed in the table above. The release period and release pattern for each tranche are reassessed at least annually. If material changes in the portfolio composition at inception, loan paydowns, or maturities indicate that the weighted average life assumption is no longer appropriate, the Company adjusts the release period and pattern prospectively. ASC 326-20 - Financial Indemnification Liability The financial indemnification liability is estimated using a probability of default (“PD”) × loss given default (“LGD”) framework, with the indemnified portfolio segmented by management’s internal risk rating scale into three tranches. Key assumptions are independently developed by management, incorporating cannabis industry-specific risk factors through a 17.5% qualitative LGD premium applied across all pooled tranches and individual evaluation of Tranche C loans. The indemnified portfolio is segmented into three tranches. Loans rated 8 or higher are individually evaluated rather than included in the pooled analysis. The expected credit loss liability as of June 30, 2026 is as follows: Schedule of Expected Credit Loss Liability Tranche Ratings Loan Balance Loss Method Reserve Tranche A - Pass Rated 2–5 $ 35,948,366 Pooled; rates 0.5 % – 1.8 % $ 419,360 Tranche B - Elevated Risk 6–7 6,537,319 Pooled; rates 2.3 % – 5.8 % 135,104 Tranche C - Specific Risk 8 8,996,394 Individual evaluation 190,558 Total $ 51,482,079 $ 745,022 The expected credit loss liability as of December 31, 2025 is as follows: Tranche Ratings Loan Balance Loss Method Reserve Tranche A - Pass Rated 2–5 $ 35,544,024 Pooled; rates 0.5 % – 1.8 % $ 406,066 Tranche B - Elevated Risk 6–8 7,168,435 Pooled; rates 3.2 % – 9.2 % 296,304 Tranche C - Specific Risk 9 9,346,394 Individual evaluation 389,402 Total $ 52,058,853 $ 1,091,772 F- 14 There is a single loan within Tranche C that continues to be individually evaluated due to its commercial and industrial (C&I) structure and collateral-dependent status. Following an independent risk review completed by the loan’s third-party servicer in May 2026, which considered debt-service coverage trends, revenue growth, and a sustained history of current payments, and applied a conservative override to the loan’s quantitatively-indicated rating the loan’s risk rating was upgraded from 9 (Doubtful) to 8 (Substandard) as of June 30, 2026. In connection with this upgrade, management revised the PD applied to the loan to 19.0% to reflect the improved risk profile; the LGD assumption of 50% was not changed, as the collateral composition and expected recovery in a default scenario are unaffected by the payment-performance improvement. As a result, the reserve on this loan decreased from $ 0.4 million as of December 31, 2025 to $ 0.2 million as of June 30, 2026. The loan remains current on all scheduled payments, and interest income continues to be recognized. Loans in the portfolio are secured primarily by real estate used for cannabis-specific purposes, including cultivation facilities, processing facilities, and retail dispensaries, and in certain cases by business assets under UCC filings. Because cannabis-use properties have limited alternative-use marketability under current federal law, management applies a two-step discount to collateral values: (i) elimination of the cannabis license premium (the “green tax”), reflecting that a non-cannabis buyer would not ascribe value to the cannabis operating license embedded in the appraised value; and (ii) a reduction to the remaining value to reflect proceeds realizable from a liquidation sale to a non-cannabis buyer. As of June 30, 2026 and December 31, 2025, this methodology results in adjusted portfolio collateral of approximately $ 48.4 million and $ 44.1 million against a gross balance of $ 51.5 million and $ 52.1 million, respectively. The portfolio has experienced minimal credit losses since program inception. Management supplements this limited loss history with cannabis industry benchmarks and peer data. Cannabis industry-specific risk including 100% single-industry concentration, Schedule I federal status, and collateral marketability constraints is reflected through an embedded qualitative LGD premium across all pooled tranches. Expected credit losses are estimated using historical loss rates derived from a five-year lookback period, reflecting 2 restructured loans out of 28 over that period. Management determined that reasonable and supportable forecasts of future economic conditions beyond the historical loss experience could not be made for this portfolio given its limited loss history and the significant uncertainty surrounding the cannabis regulatory and legal environment. Accordingly, the historical loss rates are applied without forward-looking adjustment, with immediate reversion to historical rates. The financial indemnification liability is remeasured quarterly; changes are recognized as credit loss expense or income per ASC 326-20-35-8. The inception-date contract asset is reduced as underlying loans pay down or mature and is not subject to straight-line amortization. The 65% indemnification percentage is subject to reduction under the Second Amended CAA’s listing-related adjustment clause if the Company fails to maintain Nasdaq listing standards. A reduction would result in a partial release of the ASC 460 liability to income, a downward remeasurement of the financial indemnification liability, and an impairment assessment of the related contract assets. F- 15 Rollforward of Stand-Ready Guarantee Liability and Financial Indemnification Liability Schedule of Rollforward of Stand-Ready Guarantee Liability and Financial Indemnification Liability Stand-ready guarantee liability Financial indemnification liability Total Balance, December 31, 2025 $ 1,957,083 $ 1,091,772 $ 3,048,855 Change in credit benefit ( 182,917 ) ( 133,659 ) ( 316,576 ) Balance, March 31, 2026 1,774,166 958,113 2,732,279 Balance 1,774,166 958,113 2,732,279 Additions from loans originated during the period 10,014 19,686 29,700 Change in credit benefit ( 183,042 ) ( 232,777 ) ( 415,819 ) Balance, June 30, 2026 $ 1,601,138 $ 745,022 $ 2,346,160 Balance $ 1,601,138 $ 745,022 $ 2,346,160 As of June 30, 2026, $ 0.7 million and $ 0.2 million of the stand-ready guarantee liability and financial indemnification liability, respectively, are classified as current, with the remaining $ 0.9 million and $ 0.5 million classified as non-current. As of December 31, 2025, $ 0.7 million and $ 0.4 million of the stand-ready guarantee liability and financial indemnification liability, respectively, were classified as current, with the remaining $ 1.2 million and $ 0.7 million classified as non-current. Note 8 - Revenue The following table presents the Company’s revenue disaggregated by type for the three and six months ended June 30, 2026 and June 30, 2025: Schedule of Disaggregated Revenue 2026 2025 Three Months Ended June 30 2026 2025 Account fee income $ 823,932 $ 1,009,730 Loan program income 837,938 555,971 Investment income 257,852 260,403 Safe Harbor Program income 15,018 19,230 Total $ 1,934,740 $ 1,845,334 F- 16 2026 2025 Six Months Ended June 30 2026 2025 Account fee income $ 1,692,561 $ 2,082,195 Loan program income 1,678,610 1,096,193 Investment income 504,760 560,838 Safe Harbor Program income 34,248 38,460 Total $ 3,910,179 $ 3,777,686 Note 9 - Related Party Transactions Partner Colorado Credit Union (“PCCU”) - Related Party Status The Company identifies related parties in accordance with ASC 850 and Rule 1-02(u) of Regulation S-X. PCCU is a related party because it held approximately 8.8 % and 25.2 % of the Company’s Common Stock as of June 30, 2026 and December 31, 2025, respectively. PCCU is also the largest holder of the Company’s Series B Convertible Preferred Stock and holds approximately 49 % of outstanding Series B Preferred shares and 44 % of the associated Series B Warrants as of June 30, 2026; these figures were both approximately 43 % on December 31, 2025. These factors give PCCU the ability to significantly influence the Company’s management and operating policies. Debt Cancellation Agreement On September 30, 2025, the Company and PCCU entered into a Debt Cancellation Agreement under which the approximately $ 10.7 million outstanding principal balance on the Senior Secured Promissory Note (originally dated March 29, 2023) was fully satisfied. In exchange, PCCU received: ● 13,436 shares of Series B Convertible Preferred Stock; and ● A Series B Warrant to purchase 865,200 shares of Common Stock at an exercise price of $ 7.7644 per share. PCCU’s conversion and warrant exercise rights are subject to a 4.99% beneficial ownership cap. Commercial Alliance Agreement (“CAA”) - Major Customer Concentration The Company derives substantially all of its revenue from services provided to PCCU. Revenue generated under the Second Amended CAA and the Amended CAA, as applicable, totaled $ 3.6 million and $ 3.2 million, representing 92.7 % and 83.8 % of total revenue for the six months ended June 30, 2026 and June 30, 2025, respectively. For the three months ended June 30, 2026 and June 30, 2025, revenue under these agreements totaled $ 1.9 million and $ 1.6 million, respectively, accounting for 95.7 % and 85.4 % of total revenue. Amounts due from PCCU represented 97.0 % and 97.0 % of total accounts receivable for the periods ended June 30, 2026 and December 31, 2025. The loss of, or a material change to, this relationship could have a material adverse effect on the Company’s results of operations and financial condition. Related Party Balances The following amounts with PCCU are included in the unaudited condensed consolidated balance sheets: Schedule of Related Party Balances from Balance Sheet June 30, 2026 December 31, 2025 Cash and cash equivalents $ 1,176,238 $ 6,779,040 Accounts receivable 683,887 1,009,483 Accounts payable 158,725 171,365 Note 10 - Lease The Company has a non-cancellable operating lease for its corporate office space in Golden, Colorado, which qualifies for capitalization under ASC 842 Leases. As of June 30, 2026, the Golden, Colorado lease has a remaining term of approximately 2.6 years and includes an option to extend for up to ten additional years; however, the extension option is not recognized as part of the right-of-use asset as it is not reasonably certain to be exercised. As of June 30, 2026 and December 31, 2025, the net right-of-use asset “ROU” recorded under the operating lease was $ 0.5 million and $ 0.5 million, respectively, and the corresponding lease liability was $ 0.6 million and $ 0.7 million, respectively. F- 17 The Company evaluates contracts above certain thresholds to identify leases and lease components. Lease and non-lease components are not separated for facility space leases. The Company uses its contractual borrowing rate to determine lease discount rates when an implicit rate is not available. Lease cost for the three months and six months ended June 30, 2026 and June 30, 2025, included in unaudited condensed consolidated statements of operations, is as follows: Schedule of Lease Cost 2026 2025 2026 2025 Three Months Ended Six Months Ended June 30, June 30, 2026 2025 2026 2025 Lease cost $ 60,971 $ 63,185 $ 112,403 $ 124,191 The following represents the activity for the right of use asset: Schedule of Right of Use Assets June 30, 2026 December 31, 2025 Beginning balance $ 547,186 $ 703,524 Amortization charge for the period ( 78,169 ) ( 156,338 ) Ending balance $ 469,017 $ 547,186 Other information relating to the operating lease is as follows: Weighted average remaining lease term in years 3.0 3.5 Weighted average discount rate 6.87 % 6.87 % Future minimum lease payments as of June 30, 2026 are as follows: Schedule of Future Minimum Lease Payments Year Amount 2026 (remainder of the year) $ 111,322 2027 226,705 2028 231,218 Thereafter 117,709 Total future minimum lease payments 686,954 Less: imputed interest ( 64,880 ) Operating lease liabilities 622,074 Less: current portion ( 189,902 ) Non-current portion of lease liabilities $ 432,172 Note 11 - Earnings Per Share Basic net loss per common share is calculated by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for potentially dilutive securities. Net loss attributable to common stockholders represents net income (loss) adjusted for deemed dividends on preferred stock. When the Company redeems shares of Series B Convertible Preferred Stock, the excess of the cash redemption price paid over the carrying value of the shares redeemed is treated as a deemed dividend to such stockholders. This deemed dividend is not recognized in the unaudited condensed consolidated statements of operations but is added to net loss in computing net loss attributable to common stockholders for purposes of the basic and diluted loss per share calculation. F- 18 Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares and potentially dilutive securities outstanding for the period. For the Company’s diluted net loss per share calculation, the Company uses the “if-converted method” for the Series B Convertible Preferred Stock and the “treasury stock method” for warrants and stock options. The Company applies the more dilutive of the two-class method or the if-converted / treasury stock method for each class of potentially dilutive instruments. Because the Company incurred a net loss for all periods presented, all potentially dilutive securities have been excluded from the computation of diluted net loss per share as their inclusion would be anti-dilutive. Accordingly, basic and diluted weighted-average shares outstanding are identical for both periods presented. Voluntary Market Adjustment to Series B Preferred Stock During the period from May 6, 2026 through July 31, 2026 (the “Offer Period”), pursuant to Section 8(i) of the Certificate of Designations of the Series B Convertible Preferred Stock, and with the prior written consent of the Required Holders (as defined in the Certificate of Designations of the Series B Convertible Preferred Stock), the Company temporarily reduced the conversion price of the Preferred Stock from $1.5528 to $0.65 per share. The reduced conversion price reverted to $1.5528 on August 1, 2026, for any Preferred Shares not converted during the Offer Period. Preferred Stock Conversions The Company accounted for conversions of Preferred Stock during the Offer Period as induced conversions under ASC 260-10-S99-2, applying the framework of ASC 470-20-40-13 through 40-16 by analogy, as the reduced conversion price was available only for a limited period of time. Because the Preferred Stock is equity-classified, the induced conversions, including the resulting deemed dividend, were recorded entirely within permanent stockholders’ equity, with no charge to the statement of operations. The deemed dividend for each conversion was measured, on the applicable conversion date, as the excess of the fair value of the Common Stock issued at $ 0.65 over the fair value of the shares that would have been issued at the original $ 1.5528 conversion price, using the closing market price of the Common Stock on the conversion date. During the three and six months ended June 30, 2026, holders converted 3,198 shares of Preferred Stock into 4,920,008 shares of Common Stock at the reduced conversion price, resulting in a deemed dividend of $ 0.9 million. The deemed dividend was added to the net loss in computing net loss attributable to common stockholders for purposes of basic and diluted loss per share. The deemed dividend did not affect the Company’s net loss, total stockholders’ equity, or cash flows from operations. Warrant Modification No Warrants were exercised during the three and six months ended June 30, 2026, and accordingly no deemed dividend related to the Warrant modification has been recognized. The Company evaluated the temporary reduction in the exercise price of the Series B Warrants and the mandatory cash exercise requirement as a modification of equity-classified warrants under ASC 815-40, and concluded that the Warrants remained equity-classified both before and after the modification. Issuance of Class A Common Stock During the three and six months ended June 30, 2026, the Company issued Common Stock and raised $ 1.0 million and $ 1.1 million, receptively. As per the term of the ELOC, the Company is required to redeem shares of its Series B Convertible Preferred Stock for total cash consideration raised under the ELOC, pursuant to the mandatory use of proceeds provision. The Series B Convertible Preferred Stock was originally issued at a fair value of $ 589 per share, reflecting the relative fair value allocation of the $ 800 per unit transaction price between the Series B Convertible Preferred Stock and the accompanying Series B Warrants, based on standalone fair values determined using a Monte Carlo simulation model. For the three and six months ended June 30, 2026, the redemption price exceeded the aggregate carrying value of the redeemed shares by $ 0.1 million and $ 0.2 million, respectively. This excess represents a deemed dividend to such stockholders and has been added to the net loss in computing net loss attributable to common stockholders for purposes of loss per share. The deemed dividend is a non-cash item and does not affect the Company’s unaudited net loss, unaudited stockholders’ equity, or unaudited cash flows from operations for the three and six months ended June 30, 2026. The schedule of loss per share, basic and diluted is as follows: Schedule of Earning Per Shares, Basic and Diluted For The Three Months Ended June 30, 2026 2025 Net loss $ ( 1,513,235 ) $ ( 930,715 ) Deemed dividends ( 981,146 ) - Net loss attributable to common stockholders ( 2,494,381 ) ( 930,715 ) Weighted average shares outstanding – basic and diluted 6,928,023 2,826,468 Basic and diluted net loss per share $ ( 0.36 ) $ ( 0.33 ) For The Six Months Ended June 30, 2026 2025 Net loss $ ( 3,292,452 ) $ ( 1,757,914 ) Deemed dividends ( 1,068,758 ) - Net loss attributable to common stockholders ( 4,361,210 ) ( 1,757,914 ) Weighted average shares outstanding – basic and diluted 5,647,674 2,806,841 Basic and diluted net loss per share $ ( 0.77 ) $ ( 0.63 ) F- 19 Certain share-based equity awards and warrants were excluded from the computation of dilutive earnings per share because inclusion of these awards would have had an anti-dilutive effect. The following table reflects the awards that were excluded. Schedule of Share-based Equity Awards and Warrants Excluded from Computation of Earnings 2026 2025 2026 2025 Three Months Ended June 30, Six Months Ended June 30, 2026 2025 2026 2025 Shares to be issued to Abaca shareholders - 37,500 - 37,500 Stock options 538,618 160,841 538,618 160,841 Restricted stock - 1,448 - 1,448 Conversion of preferred stock 4,440 4,440 4,440 4,440 Series B Convertible Preferred Stock (1) 41,744,615 - 41,744,615 - Warrants (1) 10,445,506 639,329 10,445,506 639,329 Total 52,733,179 843,558 52,733,179 843,558 (1) The number of shares attributable to the Series B Convertible Preferred Stock reflects the temporarily reduced $ 0.65 conversion and exercise price in effect during the Offer Period. This price reverted to $ 1.5528 on August 1, 2026, which reduced the number of as-converted shares reflected in future periods for the Series B Convertible Preferred Stock to 17,474,249 . Excluded from the computation of loss per share is the Series A Convertible Preferred Stock. The shareholders are entitled to receive dividends on shares of Series A Convertible Preferred Stock equal (on an as-if-converted-to-Common-Stock basis) to and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares of the Common Stock. No other dividends shall be paid on shares of Series A Convertible Preferred Stock. F- 20 Note 12 - Warrants Public and Private Placement Warrants As of June 30, 2026 and December 31, 2025, the Company had 287,500 public warrants and 13,205 private placement warrants to purchase Common Stock outstanding, respectively, each with an adjusted exercise price of $ 230 per share. The public and private placement warrants may only be exercised for a whole number of shares of Common Stock. The public and private placement warrants are exercisable and expire on September 28, 2027, or earlier upon redemption or liquidation. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available. Redemption of warrants will become effective when the price per share of the Common Stock equals or exceeds $ 360.00 per share. Once the warrants become redeemable, the Company may redeem the warrants: ● in whole and not in part; ● at a price of $ 0.01 per warrant; ● upon not less than 30 days’ prior written notice of redemption to each warrant holder; and ● if, and only if, the reported last sale price of the Common Stock equals or exceeds $ 360.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Common Stock and equity-linked securities) for any 20 trading days within a 30-trading day period commencing no earlier than the date the warrants become exercisable and ending on the third business day before the date on which the Company sends the notice of redemption to the warrant holders. If and when the warrant becomes redeemable by the Company, the Company may exercise its redemption rights; this is also the case if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws. If the Company calls the warrants for redemption, management will have the option to require all holders that wish to exercise the warrants to do so on a “cashless basis,” as described in the applicable warrant agreement. The exercise price and number of shares of Common Stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for the issuance of Common Stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. The private placement warrants are identical to the public warrants, except that the private placement warrants and the Common Stock issuable upon the exercise of the private placement warrants were not transferable, assignable or saleable, subject to certain limited exceptions. Additionally, the private placement warrants are exercisable on a cashless basis and non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the private placement warrants are held by someone other than the initial purchasers or their permitted transferees, the private placement warrants will be redeemable by the Company and exercisable by such holders on the same basis as the public warrants. F- 21 PIPE Warrants As of June 30, 2026 and December 31, 2025, there were 51,125 outstanding PIPE warrants to purchase Common Stock. The PIPE warrants have an adjusted exercise price of $ 100.00 per share of Common Stock to be paid in cash except if the shares underlying the warrants were not covered by an effective registration statement after the nine-month anniversary of the closing date, in which case cashless exercise is permitted. The PIPE warrants are also subject to adjustment for other customary adjustments for stock dividends, stock splits and similar corporate actions. The PIPE warrants are exercisable for a period of five years following the closing, or September 28, 2027. After the exercise of a PIPE Warrant, the Company may be required to pay certain penalties if it fails to deliver the Common Stock within a specified period of time. Abaca Warrants As of June 30, 2026 and December 31, 2025, the Company had 250,000 Abaca warrants outstanding, each exercisable to purchase one share of the Company’s Common Stock at an exercise price of $ 40.00 per share, payable in cash. The Abaca warrants become exercisable one year after the effective date of the registration statement covering the underlying shares and expire five ( 5 ) years after that date. The Company may, at its sole discretion, settle exercises of the Abaca warrants in either (i) shares of Common Stock or (ii) cash equal to the intrinsic value of the Warrants (the difference between the fair market value of the Common Stock on the date of exercise and the $ 40.00 exercise price, multiplied by the number of Warrants exercised). On November 10, 2025, the registration statement on Form S-1 covering the shares issuable upon exercise of the Abaca warrants became effective, thereby satisfying the Company’s commitment to register such shares for resale. Series B Warrants On September 30, 2025, in connection with the issuance of the Company’s Series B Convertible Preferred Stock, the Company also issued Series B Warrants to purchase an aggregate of 1,999,544 shares of Common Stock at an initial exercise price of $ 7.7644 per share, subject to adjustment. The Series B Warrants include down-round adjustment provisions and automatic price reset mechanics. The first and final automatic reset has already occurred, resetting the conversion price and exercise price to $ 1.5528 per share. While no further automatic resets are triggered, the reset required the registration of additional shares underlying the Series B Warrants. During the Offer Period, pursuant to Section 8(i) of the Certificate of Designations of the Series B Convertible Preferred Stock and with the prior written consent of the Required Holders, the Company temporarily reduced the conversion price of the Preferred Stock from $ 1.5528 to $ 0.65 per share and, pursuant to Section 2(h) of the Series B Warrants and with the prior written consent of the Required Holders, temporarily reduced the exercise price of the Series B Warrants from $ 1.5528 to $ 0.65 per share, conditioned on cash exercise and an effective registration statement for the shares underlying the Series B Warrants. The exercise price reverted at the conclusion of the Offer Period. This reduction was effected under authority separate from, and does not constitute a further adjustment of, the automatic anti-dilution reset mechanism and floor price described above; the Company’s Certificate of Designation authority for this election was previously approved by stockholders in connection with the original issuance of the Series B Convertible Preferred Stock, satisfying Nasdaq Listing Rule 5635(d) without requiring a new stockholder vote. This action was previously disclosed in the Company’s Current Report on Form 8-K filed on May 6, 2026. The Series B Warrants became exercisable on May 11, 2026 (the “Initial Exercisability Date”) and expire on May 11, 2029, the third anniversary of the Initial Exercisability Date. Each holder is subject to a 4.99 % beneficial-ownership limitation, which may be increased to up to 9.99 % upon 61 days’ prior written notice to the Company. If a registration statement covering the resale of the underlying shares is not effective at the time of exercise, the holder may elect to exercise the warrants on a cashless basis. As of June 30, 2026 and December 31, 2025, there are 9,843,676 and 1,999,544 Series B Warrants to purchase Common Stock at an exercise price of $ 1.5528 and $ 7.7644 per share, respectively. The Series B Convertible Preferred Stock and the Series B Warrants both include down-round adjustment provisions and automatic price reset mechanics. The first and final automatic reset has already occurred, resetting the conversion price and exercise price to $ 1.5528 per share. While no further automatic resets are triggered, the reset required the registration of additional shares underlying the Series B Warrants. Additional issuances of Common Stock at prices below the conversion or exercise price, except through the ELOC, may trigger further anti-dilution adjustments, thereby increasing the number of shares issuable to holders of the Series B Convertible Preferred Stock and the Series B Warrants and further diluting existing common stockholders. F- 22 The Company evaluated the Series B Warrants under ASC 815 and ASC 480. Management concluded that the Series B Warrants are indexed to the Company’s own stock and satisfy all conditions for equity classification in stockholders’ equity. In reaching this conclusion, management noted that: (i) the beneficial-ownership limitation is a timing deferral and does not introduce a non-equity observable index; (ii) the down-round feature is disregarded in the indexation analysis under ASC 815-10-15-7E; and (iii) the automatic reset provisions are fully operative before the Series B Warrants become exercisable, such that the settlement amount upon exercise is determined solely by reference to a fixed number of shares and a fixed exercise price, subject only to standard anti-dilution adjustments. Because the Series B Warrants are classified in equity, they will not be subsequently remeasured at fair value. This treatment differs from the Company’s other outstanding warrants which are classified as derivative liabilities and remeasured each reporting period. The aggregate fair value of each unit of Series B Convertible Preferred Stock and accompanying Series B Warrant was established at $ 800 , representing the price paid by unaffiliated third-party investors in an arm’s-length transaction on September 30, 2025. Because both instruments are recorded separately on the balance sheet, the Company allocated the $ 800 unit price between them on a fair value basis in accordance with ASC 470-20-30-5. The fair value of each Series B Warrant was estimated using a Monte Carlo simulation model provided by a third-party. The model produced an estimated fair value of $ 211 per Series B Warrant and $ 589 per share of Series B Convertible Preferred Stock. Both instruments are classified in permanent equity and will not be subsequently remeasured. Note 13 - Financial Instruments Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The fair value hierarchy ranks the inputs used in measuring fair value as follows: ○ Level 1 – Observable, unadjusted quoted prices in active markets ○ Level 2 – Inputs other than quoted prices included in Level 1 that are directly or indirectly observable for the asset or liability ○ Level 3 – Unobservable inputs with little or no market activity that require the Company to use reasonable inputs and assumptions The Company uses fair value measurements to record adjustments to certain financial assets and liabilities on a recurring basis. The Company may be required to record certain assets at fair value on a nonrecurring basis in specific circumstances, such as evidence of impairment. Methodologies used to determine fair value might be highly subjective and judgmental in nature; therefore, valuations may not be precise. If the Company determines that a valuation technique change is necessary, the change is assumed to have occurred at the end of the respective reporting period. F- 23 If the Company determines that a change in valuation technique is necessary, the change is assumed to have occurred as of the end of the respective reporting period. Recurring Fair Value Measurements The Company’s financial liabilities measured at fair value on a recurring basis consist of warrant liabilities, valued using Level 1 (quoted market prices) or Level 3 (internally developed option-pricing models) inputs. The Company holds no Level 2 instruments. The following table presents these liabilities by level of the fair value hierarchy as of June 30, 2026 and December 31, 2025.: Schedule of Liabilities Recorded at Fair Value June 30, 2026 December 31, 2025 Liability (in thousands) Total Fair Value Level 1 Level 3 Total Fair Value Level 1 Level 3 PIPE warrants $ — $ — $ — $ 280 $ — $ 280 Public warrants 7,734 7,734 — 10,896 10,896 — Private placement warrants — — — 14 — 14 Abaca warrants 689 — 689 28,430 — 28,430 Total liabilities $ 8,423 $ 7,734 $ 689 $ 39,620 $ 10,896 $ 28,724 Nearly all warrant values declined from December 31, 2025 to June 30, 2026, reflecting a decline in the Company’s share price over the period, as further discussed below. Nonrecurring Fair Value Measurements During the three months ended June 30, 2026, two new loans were added to the indemnified CRB loan portfolio, resulting in new stand-ready guarantee liabilities initially recognized at an aggregate fair value of $ 0.01 million, using the Level 3 insurance-pricing methodology described below. No other nonrecurring assets or liabilities were fair-valued during the period. The Company recognized a stand-ready guarantee liability under ASC 460 in connection with the Second Amended CAA with PCCU, initially at inception on October 1, 2025. The liability is measured at fair value once, at inception, and is not subsequently remeasured; it is reduced through systematic amortization as the Company is progressively released from risk on the underlying loan portfolio. As of December 31, 2025, the carrying amount of this liability was $ 2.1 million. The Company determined fair value using an insurance-pricing approach, representing the premium a third-party surety or insurer would charge to assume the same obligation. Schedule of Non-Recurring Fair Value Measurement Liability (as of initial recognition, October 1, 2025) Carrying Amount Fair Value Level 3 Input Stand-ready guarantee liability $ 2,135,000 $ 2,135,000 $ 2,135,000 F- 24 Fair Value of Financial Instruments The following tables present the carrying amounts and fair values of the Company’s financial instruments, by level of the fair value hierarchy, as of June 30, 2026 and December 31, 2025. In each case, carrying value approximates fair value. Schedule of Carrying Amount and Fair Value of Financial Instruments June 30, 2026 Carrying Amount Fair Value Level Assets Cash and cash equivalents $ 5,729,576 $ 5,729,576 Level 1 Liabilities Deferred consideration 3,000,000 3,000,000 Level 1 Public warrants 7,734 7,734 Level 1 Abaca warrants 689 689 Level 3 December 31, 2025 Carrying Amount Fair Value Level Assets Cash and cash equivalents $ 6,779,040 $ 6,779,040 Level 1 Investment in preferred securities 1,450,000 1,450,000 Level 3 Liabilities Deferred consideration 3,000,000 3,000,000 Level 1 Public warrants 10,896 10,896 Level 1 Private placement warrants 14 14 Level 3 PIPE warrants 280 280 Level 3 Abaca warrants 28,430 28,430 Level 3 Changes in Level 3 Liabilities The following tables present the changes in the Company’s Level 3 liabilities measured at fair value on a recurring basis for the six months ended June 30, 2026 and June 30, 2025. All changes during each period were attributable to fair value adjustments, with no purchases, issuances, or settlements: Schedule of Fair Value Assets Measured on Recurring Basis Six Months Ended June 30, 2026 PIPE Warrants Abaca Warrants Private Placement Warrants Balance, January 1, 2026 $ 280 $ 28,430 $ 14 Fair value adjustment ( 280 ) ( 27,741 ) ( 14 ) Balance, June 30, 2026 $ - $ 689 $ - Six Months Ended June 30, 2025 PIPE Warrants Abaca Warrants Private Placement Warrants Third Anniversary Payment Consideration Forward Purchase Derivative Balance, January 1, 2025 $ 79,512 $ 1,024,900 $ 9,632 $ 322,000 $ 7,309,580 Fair value adjustment ( 75,072 ) ( 929,827 ) ( 9,248 ) ( 235,000 ) - Balance, June 30, 2025 $ 4,440 $ 95,073 $ 384 $ 87,000 $ 7,309,580 F- 25 Quantitative Information About Level 3 Fair Value Measurements The PIPE warrants, private placement warrants, and Abaca warrants are valued using the Black-Scholes-Merton option pricing model. The following tables present the significant unobservable inputs used in these valuations as of June 30, 2026 and December 31, 2025: Schedule of Level 3 Fair Value Measurements Inputs As of June 30, 2026 PIPE Warrants Private Placement Warrants Abaca Warrants Exercise price $ 100.00 $ 230.00 $ 40.00 Share price $ 0.24 $ 0.24 $ 0.24 Expected term (years) 1.25 1.25 2.32 Volatility 117 % 117 % 117 % Risk-free rate 3.7 % 3.7 % 3.7 % As of December 31, 2025 PIPE Warrants Private Placement Warrants Abaca Warrants Exercise price $ 100.00 $ 230.00 $ 40.00 Share price $ 1.06 $ 1.06 $ 1.06 Expected term (years) 1.74 1.74 2.82 Volatility 115 % 115 % 115 % Risk-free rate 3.5 % 3.5 % 3.5 % There were no transfers between Level 2 and Level 3 of the fair value hierarchy during either period presented Assets and liabilities measured at fair value on a nonrecurring basis The Company’s only asset subject to fair value measurement on a nonrecurring basis is its right-of-use asset associated with its office lease, which is tested for impairment when indicators are present. No impairment indicators were identified during the six months ended June 30, 2026. The Company also recognizes a stand-ready guarantee liability under ASC 460 in connection with the Second Amended CAA with PCCU. A new stand-ready guarantee liability is initially recognized at fair value each time a new loan is added to the indemnified CRB loan portfolio, using the Level 3 insurance-pricing methodology described above, consistent with the market participant framework of ASC 820-10-35-9. Once recognized, each liability is not subsequently remeasured to fair value; it is instead reduced through systematic amortization as the Company is progressively released from risk on the underlying loan. During the three months ended June 30, 2026, two new loans were added to the indemnified portfolio resulting in new stand-ready guarantee liabilities measured at fair value of $ 0.01 million. F- 26 Level 3 Measurement - Significant Unobservable Inputs The ASC 460 Guarantee liability was classified as Level 3 because its fair value was determined using significant unobservable inputs for which there is no active market. The following table summarizes the valuation methodology and significant unobservable inputs used in the Level 3 measurement for those loans indemnified at October 1, 2025: Schedule of Valuation Methodology and Significant Unobservable Inputs Input Value Used Sensitivity Probability of Default -Tranches A & B (Ratings 2–5, pooled) 7.25%, derived from loan level analysis of the portfolio. An increase raises fair value Probability of Default - Tranche C (Rating 9, individually evaluated) 35%, based on Rating 9 definition, past-maturity status, and personal guarantees An increase raises fair value Loss Given Default - Tranches A & B 25.00% for Tranche A and 35% for Tranche B, inclusive of 13% cannabis-specific qualitative premium reflecting court access limitations, collateral possession restrictions, and refinancing risk An increase raises fair value Loss Given Default - Tranche C (uncollateralized gap) 50%, representing the midpoint of the Rating 9 anticipated loss range applied to the uncollateralized exposure An increase raises fair value Stand-Ready Risk Premium 120% loading applied to total expected loss, reflecting compensation for uncapped exposure, cannabis concentration risk, portfolio illiquidity, and six-year guarantee term commitment An increase raises fair value Discount Rate 4.0% risk-free rate (6-year Treasury) An increase reduces fair value Weighted Average Payout Timing Tranche A: 4 years; Tranche B: 3 years; Tranche C: 2 years; Stand-ready premium: 3 years — based on the portfolio’s contractual maturity profile A longer weighted average payout timing reduces fair value For loans entered into subsequent to October 1, 2025 (the inception date), management evaluates the stand-ready guarantee on a specific identification basis, separate from the pooled tranche inputs presented above. Loans originated under this methodology are evaluated using the tranche-specific assumptions determined at each loan’s origination date, as follows: Schedule of Financial Instruments Origination Quarter # Loans PD LGD (incl. cannabis qualitative premium) Stand-Ready Risk Premium Loading Discount Rate Weighted Avg Payout June 30, 2026 2 7.25 % 25 % 120% of expected loss 4.4 % 5 years Note 14 - Income Taxes For the three and six months ended June 30, 2026 and June 30, 2025, there was no provision for income taxes. As of June 30, 2026 and December 31, 2025, the Company had net deferred tax assets of $ 46.7 million and $ 45.8 million, respectively. The Company has recorded a full valuation allowance for both periods. The Company had a net operating loss (“NOL”) of approximately $ 75.4 million and $ 67.7 million as of June 30, 2026 and December 31, 2025, respectively. Pursuant to Section 382 of the Internal Revenue Code of 1986, as amended (“Section 382”), a corporation that undergoes an “ownership change,” generally defined as a cumulative increase of more than 50 percentage points in the stock ownership of 5 % shareholders within a rolling three-year period may have its ability to utilize pre-change net NOL carryforwards and certain other tax attributes significantly limited on an annual basis. Since inception, the Company has undergone a number of significant equity transactions, including its initial public offering, the reverse acquisition of Northern Lights Acquisition Corp., the acquisition of Abaca, various share issuances to settle obligations, and its September 2025 recapitalization. The Company has not completed a Section 382 analysis to determine whether one or more ownership changes have occurred or to quantify any resulting annual limitation. If it is determined that an ownership change has occurred, the annual limitation could materially reduce the Company’s ability to utilize its existing NOL carryforwards and other deferred tax assets to offset future taxable income. F- 27 Note 15 - Stockholders’ Equity Preferred Stock Holders of preferred stock are entitled to receive dividends only if and when dividends are paid on the Company’s Common Stock. In that event, preferred stockholders receive dividends on an as-converted-to-Common-Stock basis, in the same form as dividends paid to the Common Stockholders. No additional or separate dividends are payable on the preferred stock. The preferred stock is convertible into shares of Common Stock. The initial conversion price was $ 200 per share. The conversion price is subject to downward adjustment at five specified intervals 10, 55, 100, 145, and 190 days after the effectiveness of a registration statement covering the shares issuable upon conversion. At each adjustment date, the conversion price resets to the lower of (i) the then-current conversion price and (ii) the greater of 80% of the five-day volume weighted average price of the Common Stock and $50 (the “Floor Price”). Regardless of any price resets, each preferred stockholder retains the right to receive the total number of shares of Common Stock that would have been issuable at the adjusted conversion price based on their original investment amount. On January 25, 2023, stockholders approved a reduction in the Floor Price to $ 25.00 per share at a special meeting. Series B Convertible Preferred Stock On September 30, 2025, the Company entered into a Securities Stock Purchase Agreement (the “Series B SPA”) with certain institutional and accredited investors, pursuant to which it issued 31,052 shares of Series B Convertible Preferred Stock and accompanying Series B Warrants to purchase 1,999,544 shares of Common Stock. The aggregate gross consideration received was $ 24.3 million, consisting of $ 6.1 million from the sale of the Company’s Series B Convertible Preferred Stock and the Series B Warrants (approximately $ 5.9 million from third-party accredited investors and $ 0.2 million from management and board participation, whose participation was approved by stockholders on November 6, 2025), approximately $ 0.6 million in cash proceeds from unsecured Notes issued in August and September 2025 that were subsequently exchanged for Series B Convertible Preferred Stock and warrants at closing, along with $ 10.7 million from the cancellation of debt and $ 7.3 million from the termination of the Forward Purchase Agreement. Offering costs of $ 0.4 million were charged to additional paid-in capital. During the three months ended December 31, 2025, the Company redeemed 244 shares of its Series B Convertible Preferred Stock for total cash consideration of $ 0.5 million pursuant to the mandatory use-of-proceeds provision of the ELOC. This redemption reduced the number of shares for Series B Convertible Preferred Stock to 30,808 . The Company refers to the foregoing transactions collectively as the “September 2025 Recapitalization.” The Series B Convertible Preferred Stock has a stated value of $ 1,000 per share, ranks senior to all classes of Common Stock with respect to dividends and liquidation, and is convertible at the holder’s option into Common Stock. Both the Series B Convertible Preferred Stock and Series B Warrants are classified within permanent stockholders’ equity and are not subject to remeasurement in subsequent periods. The initial conversion price of $ 7.7644 per share was subject to automatic price resets. In January 2026, the conversion price and the Series B Warrant exercise price each reset to the contractual floor of $ 1.5528 per share, as the Company’s Common Stock was trading below the floor at the time of the reset. No further automatic resets remain. This reset significantly increases the number of shares of Common Stock potentially issuable upon conversion and exercise of these instruments. On May 6, 2026, the Company filed a registration statement on Form S-1 to register, among other things, these additional shares. At a special meeting held on November 6, 2025, stockholders approved the issuance of Common Stock upon conversion of the Series B Convertible Preferred Stock and exercise of the Series B Warrants, an increase in authorized Common Stock from 130,000,000 to 1,000,000,000 shares, and authorization for the Board to effect a reverse stock split at a ratio between 2-for-1 and 12-for-1 at its discretion. As of June 30, 2026, no reverse stock split had been effected. On May 6, 2026, the Company offered the holders of its Series B Convertible Preferred Stock and Series B Warrants a voluntary, time-limited inducement during the Offer Period to reduce the conversion price of the Preferred Stock and the cash exercise price of the Warrants from $ 1.5528 to $ 0.65 per share, a 20 % discount to the closing price of the Company’s Common Stock on the day before the beginning of the Offer Period. The conversion price and exercise price will revert to $ 1.5528 on August 1, 2026. Warrants exercised during the Offer Period, subject to an effective registration statement for the shares underlying the Series B Warrants, must be settled on a cash basis; the net–share settlement alternative previously available is not permitted during this period. Participation is voluntary; holders who do not accept retain their Preferred Stock and Warrants on the original terms. On May 6, 2026, the Company filed a registration statement on Form S-1 to register, among other things, these additional shares. As of June 30, 2026, the aforementioned registration statement had not become effective. Between May 6, 2026 and June 30, 2026, holders converted 3,198 shares of Series B Convertible Preferred Stock into 4,920,008 shares of Common Stock. No Series B Warrants have been exercised as of that date. The Company accounts for the Preferred Stock conversions as an induced conversion under ASC 260-10-S99-2, applying the induced-conversion framework in ASC 470-20-40-13 through 40-16 by analogy, given that the reduced conversion price is available only for a limited period. The voluntary market adjustment related to the Series B Preferred Stock gives rise to a deemed dividend, measured as the excess of the fair value of the consideration transferred to holders under the reduced terms over the fair value that would have been transferred under the original terms. The Company recognized a deemed dividend of $ 0.9 million in connection with the Preferred Stock conversions, measured on each respective conversion as of the modification date. The deemed dividends are entirely within permanent stockholders’ equity, and is reflected as an increase to net loss available to common stockholders in the calculation of basic and diluted loss per share for the three and six months ended June 30, 2026. The deemed dividend is considered a non-cash item and had no effect on the Company’s net loss, total stockholders’ equity, or cash flows from operations. Common Stock Holders of Common Stock are entitled to one vote for each share held. As of June 30, 2026 and December 31, 2025, there were 12,332,955 and 4,281,523 shares of Common Stock issued and outstanding, respectively. Equity Line of Credit and Related Series B Redemption Obligation On September 17, 2025, the Company entered into the ELOC with the ELOC Investor, pursuant to which the Company may issue and sell up to $ 150.0 million of newly issued shares of Common Stock at its sole discretion. The facility expires on September 17, 2028. Shares sold under the ELOC are priced at a 10% discount to the lowest intraday stock price on the draw date. The facility may be expanded up to $ 500.0 million with the mutual consent of both parties. As consideration for the ELOC Investor’s purchase commitment, the Company issued 1,000 shares of Series B Convertible Preferred Stock and a Series B Warrant to purchase 64,369 shares of Common Stock, valued at $ 0.8 million in aggregate, which was expensed in full, upon issuance. Pursuant to Amendment No. 1 to the ELOC, 25 % of net cash proceeds from each draw must be applied toward the redemption of outstanding Series B Convertible Preferred Stock at a redemption price of $ 1,200 per share. This mandatory use-of-proceeds provision represents a contractual earmark of future equity proceeds but does not create a separate liability at issuance, because no redemption obligation arises until the Company actually receives proceeds by electing to draw under the facility. Consistent with ASC 480-10-25-4 through 25-14, the Series B Convertible Preferred Stock continues to be classified in permanent equity, as any redemption remains conditional on the Company’s discretionary decision to utilize the ELOC and does not constitute an unconditional obligation to transfer assets. Under the ELOC, a “Material Adverse Effect” includes any material adverse change in the enforceability of the agreement, our results of operations, assets, business, or financial condition taken as a whole, or our ability to perform our material obligations in a timely manner. Company specific deterioration, including a significant decline in revenues or cash flows, loss of key customers or contracts, material litigation or regulatory action, failure to maintain required licenses or permits, a material weakness in internal controls, or loss of key management personnel, is not excluded from this definition and could independently trigger the ELOC Investor’s termination rights. The Company’s use of the ELOC may be limited if a delisting occurs. F- 28 The Company’s representations and warranties regarding the absence of a Material Adverse Effect must remain true and correct not only at the initial closing of the facility, but also at the time of each subsequent VWAP Purchase Notice throughout the term of the agreement. As a result, even after the facility has commenced and initial drawings have been made, any supervening adverse development could prevent the Company from accessing the remaining unfunded commitment. If a Material Adverse Effect occurs and is continuing, the ELOC Investor has the right to terminate the ELOC upon ten (10) trading days’ written notice. In that event, we would lose access to any remaining unfunded portion of the $150 million commitment. While the ELOC excludes certain broad macroeconomic, industry-wide, and geopolitical events from the definition of Material Adverse Effect, no such exclusion applies to adverse developments that are specific to our business or operations. There can be no assurance that a Material Adverse Effect will not occur during the term of the ELOC. Should one occur, and should we be unable to secure alternative financing on acceptable terms, or at all, our liquidity position, business operations, financial condition, and results of operations could be materially adversely affected. See Note 2, Basis of Presentation – Liquidity and Going Concern. During the three and six months ended June 30, 2026, the Company issued 2,907,462 and 3,131,424 shares of Common Stock under the ELOC, generating net proceeds of $ 1.0 million and $ 1.1 million, respectively, at an average price of $ 0.33 and $ 0.36 per share, respectively. These shares were sold at a contractual 10 % discount to the lowest intraday stock price on each respective draw date. The Company is obligated to apply 25 % of the proceeds to redeem the Series B Convertible Preferred Stock. As of June 30, 2026 and December 31, 2025, the Company accrued $ 0.5 million and $ 0.18 million for such redemption, respectively. For the three and six months ended June 30, 2026, the Company recorded financing costs of $ 0.2 million and $ 0.2 million, which are presented in the condensed unaudited consolidated statements of operations under “Other income expense.” This amount represents the difference between the fair market value of the shares on the settlement date and the proceeds received under the ELOC. 2022 Equity Incentive Plan The Amended and Restated - 2022 Equity Incentive Plan (the “Plan”) was approved by the Company’s stockholders on June 28, 2022. On April 30, 2025, the Plan was amended to provide that the total number of shares of Common Stock that may be issued, under the Plan will automatically increase upon the occurrence of a Dilution Event (as defined in the Plan) and on the first trading day of each calendar year, beginning with calendar year 2026, by such number of shares of Common Stock necessary to make the total shares of Common Stock authorized under the Plan equal to fifteen percent (15%) of the total outstanding shares of Common Stock on the last day of the prior calendar year (subject to a maximum annual increase of 50,000 shares of Common Stock). The Plan permits the grant of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock units, stock bonus awards, and performance compensation awards. Under the Series B Certificate of Designations and related Warrants, shares issued to employees, officers, and directors under Company stock plans are exempt from anti-dilution protection so long as the aggregate number of such issuances does not exceed 15% of the number of shares of Common Stock that were outstanding as of September 30, 2025. If the Company issues shares under its stock plans above that 15% cap, and the effective price per share is below the then-current Series B conversion price or Warrant exercise price, that issuance would trigger an automatic downward reset of both the Series B conversion price and the Warrant exercise price, along with a corresponding increase in the number of shares issuable on conversion or exercise. The Company has not issued stock appreciation rights, restricted stock, stock bonus awards, or performance compensation awards as of June 30, 2026 and December 31, 2025. As of June 30, 2026, a total of 642,229 shares of Common Stock were authorized for issuance under the Plan, of which 94,279 shares remained available for future issuances without triggering an automatic downward reset of both the Series B conversion price and the Warrant exercise price. Under the Series B Certificate of Designations and related Warrants, shares issued to employees, officers, and directors under Company stock plans are exempt from anti-dilution protection only up to 15% of the Common Stock outstanding as of September 30, 2025. Stock Options Stock options are awarded to encourage ownership of the Company’s Common Stock by employees and to provide incentives for employees to render services and to exert maximum effort for the success of the Company. The Company’s incentive stock options generally permit net share settlement upon exercise. The option exercise price, vesting schedule and exercise period are determined for each grant by the administrator (person appointed by board to administer the stock plans) of the applicable plan. The Company’s stock options generally have a 10 -year contractual term. There were no options granted during the three and six months ended June 30, 2026. The assumptions used to determine the fair value of options granted for the three and six months ended June 30, 2025, using the Black-Scholes-Merton model are as follows: Schedule of Fair Value of Options Granted Black-Scholes-Merton Model Risk-free interest rate 3.62 to 4.23 % Expected volatility (weighted-average and range, if applicable) 100 % Expected term 6 to 6.5 years F- 29 A summary of the Company’s stock option activities and related information for the six months ended June 30, 2026, is as follows: Schedule of Stock Option Activities and Related Information Stock Option No. of Stock Option Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life (in Years) January 1, 2026 538,618 $ 11.25 9.3 Granted - - - Exercised - - - Expired - - - Cancelled / Forfeited - - - June 30, 2026 538,618 $ 11.25 8.8 Vested and expected to vest, June 30, 2026 538,618 $ 11.25 8.8 A summary of the Company’s stock option activities and related information for the six months ended June 30, 2025, is as follows: Stock Option No. of Stock Option Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life (in Years) January 1, 2025 105,090 $ 98.55 7.8 Granted 150,934 7.8 9.7 Exercised - - - Expired - - - Cancelled / Forfeited ( 95,183 ) - - June 30, 2025 160,841 $ 32.70 9.0 Vested and expected to vest, June 30, 2025 160,841 $ 32.70 9.0 The following options were outstanding at their respective exercise price as of June 30, 2026 and December 31, 2025. Schedule of Options Outstanding Exercise Price Options Outstanding June 30, 2026 December 31, 2025 $1.27 25,000 25,000 $2.22 23,781 23,781 $2.40 364,893 364,893 $6.40 7,326 7,326 $7.80 5,731 5,731 $8.00 32,700 32,700 $9.68 34,884 34,884 $31.20 9,978 9,978 $62.54 6,825 6,825 $133.40 27,500 27,500 Total 538,618 538,618 F- 30 Stock compensation expense for the three months ended June 30, 2026 and June 30, 2025, is as follows: Schedule of Stock Compensation Expenses 2026 2025 For The Three Months Ended 2026 2025 Compensation and employee benefits $ 41,523 $ 23,666 Total $ 41,523 $ 23,666 Stock compensation expense for the six months ended June 30, 2026, and June 30, 2025, is as follows: 2026 2025 For The Six Months Ended 2026 2025 Compensation and employee benefits $ 100,431 $ 175,921 Professional services - 588,993 Total $ 100,431 $ 764,914 As of June 30, 2026, there was $ 0.2 million of unrecognized stock compensation expense related to outstanding stock options. The unrecognized compensation expense is expected to be recognized over a weighted-average period of approximately 1.3 years based on vesting under the award service conditions. Restricted Stock The Company did not have any outstanding restricted stock units (“RSUs”) as of June 30, 2026. A summary of the Company’s RSU activity and related information for the six months ended June 30, 2025, is presented below: Schedule of Restricted Stock Units Restricted Stock Units No. of RSU Weighted-Average Grant Date Fair Value Per RSU Weighted-Average Remaining Contractual Life (in Years) Balance, January 1, 2025 8,583 $ 26.20 1.0 Exercised ( 4,292 ) - - Forfeited ( 2,843 ) - - Balance, June 30, 2025 1,448 $ 26.20 0.5 Stock compensation expense for restricted stock awards for the period ended June 30, 2025 was $ 0.02 million. Note 16 - Commitments and Contingencies Contractual Commitments The Company has an employment agreement with its Chief Executive Officer. Under the terms of the agreement, if the contract is not renewed or is terminated without cause, the Company is obligated to pay severance equal to the CEO’s then-current annual base salary. The agreement also provides for an annual cash bonus opportunity of up to 100% of base salary, based on performance criteria established by the Board of Directors, and for long-term incentive compensation, the terms of which are to be determined by the Board of Directors. The Company is party to contractual obligations, including lease liabilities related to operating leases, and stipulated cash bonus arrangements with employees. These obligations are time-based and are reflected in the accompanying consolidated financial statements. The Company expects to meet these commitments in the ordinary course of business. In addition, the Company has entered into deferred bonus agreements with certain non-executive employees. These agreements provide for cash bonus payments upon the employee’s continued employment through specified payment dates as set forth in each individual arrangement. As of June 30, 2026, the aggregate amount of deferred bonuses outstanding under these agreements was approximately $ 0.1 million. The Company expects to fund these obligations from operating cash flows in the ordinary course of business. F- 31 Acquisition of 420 IT Solutions On December 19, 2025, Safe Harbor Managed Services LLC, a wholly-owned subsidiary of the Company, entered into an Asset Purchase Agreement with LBMW LLC (d/b/a 420 IT Solutions) and its founders. The Company accounted for this transaction as an asset purchase pursuant to ASC 805, Business Combinations. The aggregate purchase price consisted of 125,000 shares of Common Stock (“Earnout Shares”), plus the assumption of certain identified liabilities under contracts assigned to the Company. The Earnout Shares are subject to performance-based vesting over a two-year earnout period ended December 31, 2027. Intangible assets and contingent consideration are recognized as the performance conditions become probable of achievement. The Company evaluated the achievement of the performance obligation and deemed this unlikely to be reached. Therefore, the intangible assets and contingent liability were not recorded as of June 30, 2026 and December 31, 2025. If circumstances change when the revenue target is probable, then the intangible assets and a contingent liability will be recorded. The Company will continue to evaluate the achievability of the earnout performance conditions through the earnout period ending December 31, 2027. Legal and Related Matters The Company is involved in, or has been involved in, arbitrations or various other legal proceedings that arise from the normal course of its business. The ultimate outcome of any litigation is uncertain, and either an unfavorable or favorable outcome could have a material impact on the Company’s results of operations, balance sheets, and cash flows due to defense costs, and could divert management resources. The Company cannot predict the timing or outcome of these claims and other proceedings. With respect to the cases described below, the Company evaluates associated developments on a regular basis and accrues a liability when it believes a loss is probable and the amount can be reasonably estimated. Abaca - Denver County District Court On October 17, 2024, the Company filed a complaint in the District Court, captioned SHF Holdings, Inc. v. Daniel Roda, Gregory W. Ellis, and James R. Carroll , Case No. 2024CV33187. The lawsuit arises from a dispute over the terms of the Company’s October 2022 acquisition of Abaca pursuant to a merger agreement (the “Merger Agreement”) that was subsequently amended in November 2022 and in October 2023 (the “Second Amendment”). The Second Amendment restructured certain merger consideration, including introducing warrants and modifying payment timing. The defendants contend the Second Amendment is invalid under Delaware law and seek to have it set aside, which would reinstate the original payment terms and potentially increase the Company’s obligations. The Company maintains that the Second Amendment was validly executed and is binding. On November 21, 2024, at the Company’s request, the disputed merger payment of $ 3.0 million was deposited into the Denver County, Colorado District Court’s registry pending resolution of the dispute. This amount has been reflected in the Company’s consolidated balance sheet. On December 19, 2024, the defendants filed an answer and counterclaims against the Company. On April 18, 2025, the District Court issued an order denying the Company’s motion to dismiss most of the counterclaims, but the District Court did dismiss claims against the Company’s Chairman, Fred Niehaus, with prejudice. The District Court also clarified that the Delaware statutes cited by the defendants govern pre-closing amendments and do not authorize post-merger amendments altering consideration, a finding that is consistent with the Company’s legal position. On April 23, 2026, the District Court issued an omnibus order on cross-motions for summary judgment in the matter. The Court denied the Company’s motion for summary judgment in its entirety. The Court granted the counterclaim plaintiffs’ cross-motion in part, primarily ruling that the Second Amendment to the Merger Agreement is void ab initio under Section 251(d) of the Delaware General Corporation Law, and because of that ruling, that the Company breached the original Merger Agreement with respect to the first anniversary parent shares. Damages on this counterclaim are set for trial on August 10-11, 2026. The Court also denied both parties’ motions on the counterclaim concerning the second anniversary cash consideration payment of $ 3.0 million and denied the counterclaim plaintiffs’ motion on the Company’s declaratory judgment claim; those claims are also set for trial on August 10–11, 2026. The Court’s order is not final, it is an appealable order under C.R.C.P. 54(b). The $ 3.0 million previously deposited into the Court’s registry in November 2024 remains reflected in the Company’s condensed unaudited consolidated financial statements. The Company intends to continue defending its positions vigorously. The range of loss is $ 0 to $ 7.8 million. An adverse resolution could have a material adverse effect on the Company’s financial position, results of operations, and cash flows. F- 32 The Company currently assesses a loss as reasonably possible but not probable. No damages have been determined by the Court; the Omnibus Order expressly reserves the damages methodology, standard, and quantum for a future hearing. The defendants’ sole designated damages expert has not been qualified, and the Company’s motion to exclude that expert remains pending. Because the amount of any potential loss cannot be reasonably estimated at this time, no accrual has been recorded for this contingency beyond the $ 3.0 million already reflected in the financial statements. Nasdaq Listing Compliance As a condition of continued listing, the Company is required to maintain (i) a minimum of $ 2.5 million in stockholders’ equity under Nasdaq Listing Rule 5550(b)(1), and (ii) a minimum closing bid price of $ 1.00 per share for 30 consecutive business days under Nasdaq Listing Rule 5550(a)(2). The Company continuously monitors its compliance with these requirements. As of June 30, 2026, the Company’s stockholders’ equity was approximately $6.1 million, which exceeds the $ 2.5 million minimum. On April 22, 2026, the Company received a letter from the listing qualifications department staff of Nasdaq notifying the Company that for the last 30 consecutive business days the Company did not maintain a minimum closing bid price of $ 1.00 per share for its Common Stock, as required by Nasdaq Listing Rule 5550(a)(2). The notice has no immediate effect on the listing of the Company’s Common Stock or warrants, and the Company’s Common Stock and warrants continue to trade on Nasdaq under the symbols “SHFS” and “SHFSW,” respectively. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided with a compliance period of 180 calendar days, or until October 19, 2026, to regain compliance with the minimum bid price requirement. The notice states that to regain compliance the closing bid price of the Company’s Common Stock must meet or exceed $ 1.00 for a minimum of 10 consecutive business days. At a special meeting held on November 6, 2025, stockholders approved authorization for the Board to effect a reverse stock split at a ratio between 2-for-1 and 12-for-1 at its discretion. As of June 30, 2026, no reverse stock split had been effected. If the Company does not regain compliance by October 19, 2026, the Company may be eligible for a second compliance period for up to an additional 180 days. In connection with any extension period, if it appears that the Company will not be able to regain compliance with Nasdaq Listing Rule 5550(a)(2), or if the Company is not otherwise eligible, the Nasdaq staff will provide notice to the Company that its securities will be subject to delisting. At that time, the Company may appeal any such delisting determination to a Hearings Panel. The Company intends to actively monitor the bid price and may evaluate other available options to resolve the deficiency and regain compliance with the Nasdaq Listing Rules. While the Company is exercising diligent efforts to maintain the listing of its Common Stock and warrants on Nasdaq, there can be no assurance that the Company will be able to regain or maintain compliance with the foregoing or other Nasdaq listing standards. On July 22, 2026, the SEC approved a proposed Nasdaq rule change (SR-NASDAQ-2026-004), originally filed with the SEC on January 13, 2026, that would establish a new continued listing requirement based on a minimum Market Value of Listed Securities (“MVLS”) of $ 5.0 million for companies listed on the Nasdaq Global Select Market, Nasdaq Global Market, and Nasdaq Capital Market. As approved, the rule would not provide for a compliance or cure period; a company whose MVLS remains below $ 5.0 million for thirty consecutive business days would receive a Staff Delisting Determination and would become immediately subject to suspension and delisting, subject to the right to appeal to a Nasdaq Hearings Panel. Subsequent to the SEC’s approval, on July 29, 2026, the SEC notified Nasdaq that it had received notices of intention to petition for review of the July 22, 2026 approval order and that, as a result, the order is stayed until the SEC orders otherwise. Accordingly, the new MVLS requirement is not currently in effect. The SEC may lift the stay at any time, and there can be no assurance as to the ultimate outcome of the petition for review or the timing of any further SEC action. If the stay is lifted and the rule becomes effective, based on the Company’s current stock price and number of shares outstanding as of the date of this filing, the Company may not be in compliance with this requirement and could become subject to immediate suspension and delisting proceedings as soon as thirty consecutive business days after the rule takes effect, without the benefit of a compliance period. Note 17 - Subsequent Events The Company has evaluated events and transactions occurring after June 30, 2026, through the date these financial statements were issued, and has identified the following matters requiring disclosure. Unless otherwise noted, these are non-recognized subsequent events under ASC 855-10 that do not adjust amounts in the June 30, 2026, financial statements but are material enough to warrant disclosure. Compensation Arrangements In July 2026, the Board approved a Retention Plan covering certain named executive officers and directors. The plan provides cash retention payments upon a change in control and enhanced compensation during periods of insolvency, subject to continued service and other plan conditions. The aggregate potential payments to the named executive officers are approximately $1.0 million upon a change in control (plus related COBRA benefits) and approximately $0.4 million annually in additional compensation during an insolvency period. F- 33 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. References in this section to “we,” “us,” “our,” “SHF,” or the “Company” refer to SHF Holdings, Inc. References to “management” refer to our officers and Board of Directors. The following discussion and analysis of our financial performance and results of operations should be read in conjunction with our consolidated financial statements and the notes to those financial statements included elsewhere in this Form 10-Q. This discussion contains forward-looking statements based upon current expectations that involve risks and uncertainties. See “Cautionary Note Regarding Forward-Looking Statements.” Our actual results may differ materially from those contained in or implied by any forward-looking statements. Overview The Company was founded in 2015 by PCCU and is headquartered in Golden, Colorado. We operate a proprietary compliance technology platform that enables financial institutions to provide banking and lending services to cannabis related businesses (“CRBs”) operating legally under applicable state law. Because cannabis remains a federally controlled substance under the Controlled Substances Act (“CSA”), most financial institutions have historically been unwilling to serve CRBs, creating significant demand for the compliance infrastructure and risk management services we provide. We are not a bank or credit union and do not hold customer deposits. Instead, we provide compliance monitoring, onboarding, and reporting services that allow our financial institution clients to accept and maintain CRB deposit accounts in a manner consistent with Bank Secrecy Act (“BSA”) requirements, FinCEN guidance, and applicable anti-money laundering regulations. Through our financial institution clients, we facilitate access to business checking and savings accounts, cash management, commercial lending, remote deposit, automated clearing house payments, wire transfers, and courier services through third-party relationships. By enabling CRBs to deposit cash receipts through regulated financial institutions, our platform helps to reduce the safety risks associated with high cash volumes and gives CRBs access to financial tools that help them operate more efficiently. In select markets, we also license our Program to other financial institutions, providing them know your customer due diligence tools, compliance monitoring, program management support, and regulatory exam assistance. We generate revenue primarily through account fee income based on the number of active accounts and the size of deposit balances in such accounts, loan program income on CRB loans we source and service on behalf of our financial institution clients, and investment income earned on CRB-related deposits held at those institutions. Since 2015, the Company has assisted in the processing of more than $36.0 billion in cannabis-related depository funds and has supported its financial institution clients through more than 25 state and federal banking examinations. Relationship with PCCU PCCU is the Company’s primary financial institution client and the source of a significant majority of its revenue. The relationship is governed by the Second Amended CAA, which replaced the First Amended Commercial Alliance Agreement (the “First Amended CAA”) effective October 1, 2025. The First Amended CAA introduced several significant changes to the Commercial Alliance Agreement, including (i) the elimination of the Company’s indemnification obligations for loan-related losses, (ii) a reduction in the Company’s loan program income share to approximately 35% to reflect the incremental risk absorbed by PCCU in connection with the elimination of our indemnification obligations, (iii) the replacement of a multiple per-account fee structure with a single asset hosting fee equal to 1.00% of average daily CRB deposit balances that increased to 1.30% in the event balances exceeded $130 million, and (iv) us receiving 100% of investment income on CRB deposits. The Second Amended CAA fundamentally restructured the economics of the PCCU relationship. The primary changes were that (i) the Company’s share of loan program income increased from approximately 35% to up to 65%, reflecting the completion of the September 2025 recapitalization; (ii) the Company now receives up to 65% of loan program income generated by PCCU’s CRB loan portfolio in exchange for being obligated to indemnify PCCU for up to 65% of net losses of a default on any loan covered by the Second Amended CAA, with no contractual cap on total exposure; and (iii) the asset hosting fee structure transitioned from a flat rate to a tiered marginal rate schedule based on average daily deposit balances, with rates ranging from 0.50% on the first $25 million to 1.25% on balances above $125 million, resulting in estimated annual savings of approximately $0.3 million compared to the rates contained in the First Amended CAA. The concentration of our business with PCCU and the re-assumption of the indemnification obligation each represent material risks to the Company. Any loss of or material adverse change to the PCCU relationship, or any significant loan defaults in the CRB portfolio for which we are required to fund indemnification payments, could have a material adverse impact on our liquidity, financial condition, and results of operations. 6 Industry and Regulatory Environment Federal Regulatory Developments — Rescheduling to Schedule III The federal regulatory environment for cannabis continues to evolve in ways the Company believes are material to its industry. In August 2023, the U.S. Department of Health and Human Services recommended that the Drug Enforcement Administration (“DEA”) reschedule cannabis from Schedule I to Schedule III of the CSA, and in May 2024 the U.S. Department of Justice (“DOJ”) issued a Notice of Proposed Rulemaking to that effect, although the rescheduling process was stayed and effectively stalled for much of 2025. On December 18, 2025, President Trump signed an Executive Order directing the Attorney General to expeditiously complete the rulemaking process to reschedule cannabis to Schedule III. On April 23, 2026, the DOJ issued a final order rescheduling Food and Drug Administration-approved cannabis products and products regulated under state medical marijuana licenses to Schedule III. The DEA held an expedited administrative hearing between June 29, 2026 and July 15, 2026 to consider broader rescheduling from Schedule I to Schedule III. Legal challenges are anticipated, and the ultimate timing of any final rule remains uncertain. While medical cannabis produced and sold by state-licensed operators who have applied for DEA licenses is now Schedule III, all other cannabis remains a Schedule I controlled substance under federal law, which creates ongoing legal and compliance risks for us and for the financial institutions we serve. Proposed federal legislation, including the SAFER Banking Act, could expand the availability of banking services to CRBs and increase competition in our market. Conversely, changes in federal or state enforcement priorities could adversely affect our clients and, in turn, our business. We monitor legislative and regulatory developments closely, as they are a primary driver of both the demand for, and the risks associated with, our services. The Company believes the most financially material consequence of rescheduling would be the elimination of Section 280E of the Internal Revenue Code, which currently prohibits cannabis businesses from deducting ordinary and necessary business expenses and results in effective federal tax rates materially higher than those of other industries, and its elimination could improve cash flows and profitability for state-legal cannabis operators. On June 17, 2026, Nasdaq published Nasdaq listing library rule number 1877 that allows state-licensed medical marijuana companies that register with the DEA and operate in compliance with federal law are eligible to list on Nasdaq if they can provide an opinion of counsel from a law firm, acceptable to Nasdaq, with expertise in controlled substance regulatory compliance confirming that the company operates in compliance with the DOJ order and applicable requirements of the CSA. This potentially allows the Company to hold medical cannabis licenses without jeopardizing its Nasdaq listing. Key Metrics Management monitors the following operational metrics to assess the health and trajectory of the core banking services business. Total account balances, number of accounts and average account balances Our ability to generate account fee income and investment income is directly tied to the number of active CRB accounts we manage and the total deposit balances maintained at our financial institution clients. We monitor account activity including daily deposits, withdrawals, and ending balances on an ongoing basis. Average account balances represent the average aggregate ending balance of onboarded and monitored CRB deposits held at financial institution clients over the revenue generating period. at period end. Average account balance is total account balances divided by total active accounts at period end. Trailing 14-day average balances represent the aggregate ending balance of onboarded and monitored CRB deposits held at financial institution clients over the 14 calendar days at the period end and represent a period end balance that smooths our clients’ two-week payroll cycles. Account Fees per Average Active Account Our fee income is generated from active accounts and account-level transaction activity. We track account openings and closings on a daily, weekly, and monthly basis and monitor account fees per average active account as an indicator of pricing efficiency and revenue quality. For The Three Months Ended June 30, 2026 2025 Change Change (%) Average deposit balance (1 ) $ 108,413,858 $ 101,463,819 $ 6,950,039 6.8 % Trailing 14-day average account balance (2 ) $ 108,933,064 $ 100,915,015 $ 8,018,049 7.9 % Average monthly account fees (3 ) $ 229,360 $ 276,586 $ (47,226 ) (17.1 )% Average active accounts (4 ) 766 762 4 0.5 % Average account balance (5 ) $ 141,532 $ 133,155 $ 8,377 6.3 % Average monthly fees per account (6 ) $ 299 $ 363 $ (64 ) (17.6 )% For The Six Months Ended June 30, 2026 2025 Change Change (%) Average deposit balance (1 ) $ 107,327,311 $ 103,756,620 $ 3,570,691 3.4 % Trailing 14-day average account balance (2 ) $ 108,933,064 $ 100,915,015 $ 8,018,049 7.9 % Average monthly account fees (3 ) $ 235,218 $ 285,433 $ (50,215 ) (17.6 )% Average active accounts (4 ) 765 772 (7 ) (0.9 )% Average account balance (5 ) $ 140,358 $ 134,400 $ 5,958 4.4 % Average monthly fees per account (6 ) $ 308 $ 370 $ (62 ) (16.8 )% (1) Represents the average deposit balance over the period. (2) Represents the average balance for the 14 calendar days ending on June 30th, which represents a period end balance that smooths our clients’ two-week payroll cycles. (3) Reported account activity fee revenue. (4) Represents the average of ending active accounts for each of the three months therein. (5) Refer to the below section – Discussion of Results of our Operations for additional discussion of trends. (6) Represents the average of account activity fee revenue for the three and six months therein. For the three and six months ended June 30, 2026, the Company continued to grow its deposit base and expand the scale of its client relationships. Average deposit balances increased $7.0 million, or 6.8%, to $108.4 million for the three-month period, and $3.6 million, or 3.4%, to $107.3 million for the six-month period, each compared to the same periods last year. Active accounts grew 0.5% for the three-month period, while the six-month period reflected a modest 0.9% reduction in active accounts; in each case, average account balance increased, rising 6.3% to $0.1 million for the three-month period and 4.4% to $0.1 million for the six-month period. Average Account fee revenue was $0.2 million for both the three- and six-month periods, decreasing 17.1% and 17.6%, respectively, compared to the prior year periods, as average fees collected per account decreased 17.6% to $299 for the three-month period and 16.8% to $308 for the six-month period. This decline reflects a continued shift in the account portfolio toward larger, higher-balance relationships, which generate proportionately lower fee revenue relative to their deposit contribution but can support the Company’s growing deposit base and associated investment income. 7 Recent Events Board of Directors and Executive Officers On April 20, 2026, Sundie Seefried tendered her resignation as a member of the Board. Ms. Seefried’s departure was not the result of any disagreement with the Company on any matter relating to its operations, policies or practices. On April 22, 2026, the Board appointed each of Sean Tonner and Tyler Klimas as directors, effective immediately, and the Board also approved an increase in the number of directorships on the Board from five to six. On May 8, 2026, Richard Carleton informed the Board of Directors of his decision not to be considered for reelection to the Board at the Company’s 2026 annual meeting of stockholders (the “2026 Annual Meeting”). On June 17, 2026, the Company’s stockholders elected Jonathon F. Niehaus and Sean Tonner to serve as Class II directors of the Company at the 2026 Annual Meeting. On July 7, 2026, Douglas Beck informed the Company of his decision to resign from his roles at the Company effective July 31, 2026. On July 15, 2026, Michael Regan was appointed as the Company’s Chief Operating Officer and Secretary. Nasdaq Listing Compliance As a condition of continued Nasdaq listing, the Company is required to maintain stockholders’ equity of at least $2.5 million under Nasdaq Listing Rule 5550(b)(1) and a minimum closing bid price of $1.00 per share for 30 consecutive business days under Nasdaq Listing Rule 5550(a)(2). On April 22, 2026, the Company received a letter from the listing qualifications department staff of Nasdaq notifying the Company that for the last 30 consecutive business days the Company did not maintain a minimum closing bid price of $1.00 per share for its Common Stock, as required by Nasdaq Marketplace Rule 5550(a)(2). The notice had no immediate effect on the listing of the Company’s Common Stock or warrants. Pursuant to Nasdaq Marketplace Rule 5810(c)(3)(A), the Company was provided with a compliance period of 180 calendar days, or until October 19, 2026, to regain compliance with the minimum bid price requirement. The notice states that to regain compliance the closing bid price of the Company’s Common Stock must meet or exceed $1.00 for a minimum of 10 consecutive business days. If the Company does not regain compliance by October 19, 2026, the Company may be eligible for a second compliance period for up to an additional 180 days. At a special meeting held on November 6, 2025, stockholders approved authorization for the Board to effect, at its discretion, a reverse stock split at a ratio between 2-for-1 and 12-for-1; as of June 30, 2026, no reverse stock split had been effected. If the Company is ultimately unable to regain compliance, Nasdaq staff would notify the Company that its securities are subject to delisting, which determination the Company may appeal to a Hearings Panel. There can be no assurance the Company will regain or maintain compliance with this or other Nasdaq listing standards. On July 22, 2026, the SEC approved a proposed Nasdaq rule (originally filed with the SEC on January 13, 2026) that would require Nasdaq-listed companies to maintain a minimum market value of listed securities (“MVLS”) of at least $5 million. As approved, the rule provides that if a company’s MVLS remains below $5 million for 30 consecutive business days, it would become immediately subject to suspension and delisting, without any cure or compliance period. Subsequent to the SEC’s approval, on July 29, 2026, the SEC notified Nasdaq that it had received notices of intention to petition for review of the July 22, 2026 approval order and that, as a result, the order is stayed until the SEC orders otherwise. Accordingly, the new MVLS requirement is not currently in effect, and there can be no assurance as to whether or when the stay will be lifted or the rule will become effective. See Part II, Item 1A. “ Risk Factors–A new Nasdaq rule will delist companies whose market capitalization falls below $5 million for 30 or more consecutive trading days .” There can be no assurance that the Company will maintain compliance with these or any other Nasdaq listing requirements in the future. Failure to do so could ultimately result in the delisting of the Company’s Common Stock, which would adversely affect stockholders’ ability to trade their shares and the Company’s ability to raise capital. Voluntary Market Adjustment to Series B Preferred Stock and related Warrants On May 6, 2026, the Company offered the holders of its Series B Convertible Preferred Stock and Series B Warrants a voluntary, time-limited inducement running from May 6, 2026, through July 31, 2026 (the “Offer Period”) to reduce the conversion price of the Preferred Stock and the cash exercise price of the Warrants from $1.5528 to $0.65 per share, a 20% discount to the closing price of the Company’s Common Stock on the day before the offer. The conversion price and exercise price will revert to $1.5528 on August 1, 2026. Warrants exercised during the Offer Period, subject to an effective registration statement, must be settled on a cash basis; the net share settlement alternative previously available is not permitted during this period. Participation is voluntary; holders who do not accept retain their Preferred Stock and Warrants on the original terms. On May 6, 2026, the Company filed a registration statement on Form S-1 to register, among other things, these additional shares. As of June 30, 2026, the aforementioned registration statement had not become effective. Between May 6, 2026 and June 30, 2026, holders converted 3,198 shares of Series B Convertible Preferred Stock into 4,920,008 shares of Common Stock. No Series B Warrants have been exercised as of that date. The Company accounts for the Preferred Stock conversions as an induced conversion under ASC 260-10-S99-2, applying the induced-conversion framework in ASC 470-20-40-13 through 40-16 by analogy, given that the reduced conversion price is available only for a limited period. The voluntary market adjustment related to the Series B Preferred Stock gives rise to a deemed dividend, measured as the excess of the fair value of the consideration transferred to holders under the reduced terms over the fair value that would have been transferred under the original terms. The Company recognized a deemed dividend of $0.9 million in connection with the Preferred Stock conversions, measured on each respective conversion as of the May 6, 2026, modification date. The deemed dividends are entirely within permanent stockholders’ equity, and is reflected as an increase to net loss available to common stockholders in the calculation of basic and diluted loss per share for the three and six months ended June 30, 2026. The deemed dividend is considered a non-cash item and had no effect on the Company’s net loss, total stockholders’ equity, or cash flows from operations. Components of our Results of Operations Revenue The Company generates revenue through four primary streams. Account fee income consists of fees charged to financial institution clients based on the number of active CRB accounts managed, account-level transaction activity, and deposit balances. These fees compensate the Company for providing BSA compliance monitoring, onboarding, account management, and related regulatory reporting services. Loan program income represents the Company’s contractual share of interest earned on CRB loans originated and serviced by the Company on behalf of its financial institution clients, primarily PCCU. The Company’s share of loan program income is currently determined in accordance with the Second Amended CAA. Investment income represents interest earned on CRB deposit balances held at financial institution clients and is based on the prevailing market rates applied to those balances. In addition, the Company earns fees from licensing its proprietary Program to other financial institutions and from ancillary services provided to businesses serving the cannabis industry. 8 Operating Expenses Operating expenses consist of compensation and employee benefits, professional services, general and administrative expenses, rent expense, and provision (benefit) for credit losses. ● Compensation and employee benefits consist of employee wages, payroll taxes, employee benefits, and non-cash stock-based compensation. Stock-based compensation has increasingly been used as a component of total compensation to preserve cash and align employee and consultant incentives with the performance of the Common Stock. ● Professional services consist of legal fees, audit and accounting fees, general consulting fees, and board-related fees. Legal fees include both ongoing corporate legal services and costs associated with the Company’s active litigation matters. ● General and administrative expenses include the asset hosting fee paid to PCCU under the First Amended CAA or the Second Amended CAA, as applicable, insurance, advertising and marketing, travel and entertainment, franchise taxes, and other office and operating expenses. The asset hosting fee represents consideration paid to PCCU for access to its banking platform, regulated deposit infrastructure, and bank charter and is one of the largest components of general and administrative expenses. See “Related Party Relationships.” ● Rent expense reflects the cost of the Company’s corporate office. The Company closed its Arkansas office during 2025, thereby reducing its ongoing rent obligations. ● Provision (benefit) for credit losses reflects the Company’s estimated losses on loans it is obligated to indemnify. Under the Second Amended CAA, we receive up to 65% of loan program income generated by PCCU’s CRB loan portfolio. In exchange, we are obligated to indemnify PCCU for up to 65% of net losses of a default on any loan covered by the Second Amended CAA. This obligation has no maximum dollar limit and covers principal, accrued interest, fees, legal costs, collection costs, and collateral disposition costs, net of any recoveries. Discussion of our Results of Operations for the Three and Six Months Ended June 30, 2026 Compared to the Three Months Ended June 30, 2025 Revenue Three Months Ended June 30, 2026 2025 Change ($) Change (%) Account fee income $ 823,932 $ 1,009,730 $ (185,798 ) (18.4 )% Loan program income 837,938 555,971 281,967 50.7 % Investment income 257,852 260,403 (2,551 ) (1.0 )% Safe Harbor Program income 15,018 19,230 (4,212 ) (21.9 )% Total $ 1,934,740 $ 1,845,334 $ 89,406 4.84 % Six Months Ended June 30, 2026 2025 Change ($) Change (%) Account fee income $ 1,692,561 $ 2,082,195 $ (389,634 ) (18.7 )% Loan program income 1,678,610 1,096,193 582,417 53.1 % Investment income 504,760 560,838 (56,078 ) (10.0 )% Safe Harbor Program income 34,248 38,460 (4,212 ) (11.0 )% Total $ 3,910,179 $ 3,777,686 $ 132,493 3.5 % Account fee income Account fee income decreased by $0.2 million, or 18.4%, for the three months ended June 30, 2026, compared to the same period in 2025. The decline was primarily due to lower revenue from a merchant service partner, which reduced account fee income by approximately $0.2 million year over year. Account fee income decreased by $0.4 million, or 18.7%, for the six months ended June 30, 2026, compared to the same period in 2025. The decline was primarily due to lower revenue from a merchant service partner, which reduced account fee income by approximately $0.2 million year over year. In addition, lower average fees collected from PCCU-hosted accounts contributed approximately $0.1 million to the overall decrease. Investment income For the three months ended June 30, 2026, investment income was $0.3 million, compared to $0.3 million for the three months ended June 30, 2025. The average investable deposit base grew to $45.8 million from $35.3 million between those periods, but the benefit of that growth was offset by a decline in the Interest on Reserve Balances (IORB) rate from 4.40% to 3.65%. For the six months ended June 30, 2026, investment income was $0.5 million, compared to $0.6 million for the six months ended June 30, 2025, a decrease of $0.1 million, or 10.0%. The average investable deposit base grew to $46.8 million from $35.1 million between those periods, but the benefit of that growth was more than offset by a decline in the IORB rate from 4.40% to 3.65%. Loan program income For the three months ended June 30, 2026, loan program income was $0.8 million, compared to $0.6 million for the three months ended June 30, 2025, an increase of $0.3 million, or 50.7%. For the six months ended June 30, 2026, loan program income was $1.7 million, compared to $1.1 million for the six months ended June 30, 2025, an increase of $0.6 million, or 53.1%. The increase for both periods was primarily driven by the Second Amended CAA, which increased the Company’s share of loan program income to 65% from approximately 35% under the First Amended CAA, together with less than $0.02 million of additional loan origination fees collected on refinanced loans in the three-month period. This increase was partially offset by a decline in the average loan portfolio to $51.5 million for the six months ended June 30, 2026, from $53.1 million for the same period in 2025, reflecting fewer loans outstanding year over year, the impact of which was mitigated by improved retention of the Company’s share of loan program income under the Second Amended CAA. 9 Operating expenses For The Three Months Ended June 30, 2026 2025 Change ($) Change (%) Compensation and employee benefits $ 1,477,615 $ 1,583,051 $ (105,436 ) (6.7 )% General and administrative expenses 886,751 457,803 428,948 93.7 % Professional services 792,804 712,337 80,467 11.3 % Rent expense 60,971 63,185 (2,214 ) (3.5 )% Amortization of contract asset 129,072 - 129,072 100.0 % Credit benefit (386,119 ) - (386,119 ) 100.0 % Total operating expenses $ 2,961,094 $ 2,816,376 $ 144,718 5.1 % For The Six Months Ended June 30, 2026 2025 Change ($) Change (%) Compensation and employee benefits $ 3,138,273 $ 2,955,532 $ 182,741 6.2 % General and administrative expenses 1,955,151 1,448,629 506,522 35.0 % Professional services 1,938,613 2,211,871 (273,258 ) (12.4 )% Rent expense 112,403 124,191 (11,788 ) (9.5 )% Amortization of contract asset 258,144 - 258,144 100.0 % Credit benefit (702,695 ) - (702,695 ) 100.0 % Total operating expenses $ 6,699,889 $ 6,740,223 $ (40,334 ) (0.6 )% Total operating expenses For the three months ended June 30, 2026, total operating expenses increased by $0.2 million, or 5.1%, to $3.0 million, compared to $2.8 million for the same period in 2025. For the six months ended June 30, 2026, total operating expenses decreased $0.04 million, or 0.6%, to $6.7 million, compared to $6.7 million for the same period in 2025. For the three-month period, the change was primarily driven by a credit benefit recognized during the period and lower compensation and employee benefits expense, partially offset by higher general and administrative expenses. Compensation and employee benefits For the three months ended June 30, 2026, compensation and employee benefits expenses decreased by $0.1 million, or 6.7%, to $1.5 million, compared to $1.6 million for the same period in 2025. The decrease was primarily driven by savings from the departure of certain executive officers, partially offset by the impact of staff increases and salary adjustments to support strategic growth initiatives. For the six months ended June 30, 2026, compensation and employee benefits expenses increased by $0.2 million, or 6.2%, to $3.1 million, compared to $3.0 million for the same period in 2025. The increase was primarily driven by investments in staff to support strategic growth initiatives, offset in part by savings from the departure of certain executive officers and a decrease in stock-based compensation expense, reflecting lower fair values of awards granted during 2026 and the completed vesting of certain prior-period grants. General and administrative expenses For the three and six months ended June 30, 2026, general and administrative expenses increased $0.4 million and $0.5 million, or 93.7% and 35.0%, to $0.9 million and $2.0 million, compared to $0.5 million and $1.4 million for the same periods in 2025, respectively. The increase was primarily due to strategic investments in (i) investor related marketing intended to increase market awareness of the Company’s business developments, (ii) brand marketing intended to build awareness of the Company’s expanded capabilities, including its broader lending program, its expanded consulting support for CRBs under its Managed Services offering, and its efforts to onboard additional financial institution clients to its platform, (iii) marketing of the Company’s compliant and transparent pooled employer retirement plan, which has facilitated more in-depth conversations with multi-state operators that would not otherwise bank through the Company, and (iv) the development of infrastructure supporting the Company’s efforts to embed artificial intelligence capabilities into its operating environment resulting in higher subscription costs and, for the three-month period, higher franchise tax expense as described below. The Company partially recovered its investor relations marketing investment through issuances under its ELOC facility during the period. These increases were partially offset by lower PCCU account hosting fees under the Second Amended CAA. General and administrative expenses for the three months ended June 30, 2026, also reflected a year-over-year franchise tax variance of $0.3 million. This variance was driven by a refund of a prior-year franchise tax overpayment recognized in the three months ended June 30, 2025, rather than any increase in the Company’s underlying franchise tax expense for the current period. Franchise tax expense is also affected by the number of the Company’s authorized shares, an increase in which is amortized over an annual period and was not material to the three-month period. Professional services For the six months ended June 30, 2026, professional services expenses decreased $0.3 million, or 12.4%, to $1.9 million, compared to $2.2 million for the same period in 2025, driven primarily by lower litigation-related legal fees, the absence of a one-time litigation settlement expense recognized in 2025, and the absence of a stock-based compensation award granted in 2025, which reduced expense by approximately $0.6 million. These decreases were partially offset by higher director fees, reflecting a one-time bonus and an increase in the number of directors eligible for board fees. For the three months ended June 30, 2026, professional services expenses increased less than $0.1 million, or 11.3%, to $0.8 million, compared to $0.7 million for the same period in 2025, as a reduction in litigation-related legal fees was offset by higher director fees and increased business consulting expenses. The comparatively modest three-month movement, against a more meaningful six-month decline, reflects the stabilization of the Company’s legal fee base following the resolution of litigation matters in prior periods. 10 Rent expense For the three and six months ended June 30, 2026, rent expense decreased by less than $0.01 million, or 3.5% and 9.5%, respectively, to $0.1 million for each period, compared to $0.1 million for the same periods in 2025, primarily due to the closure of the Company’s Arkansas office during 2025. Amortization of contract asset For the three and six months ended June 30, 2026, amortization of the contract asset was $0.1 million and $0.3 million, respectively, compared to $0 for the same periods in 2025. This represents the straight-line amortization of costs capitalized to secure the Second Amended CAA, discussed in Note 6 to the accompanying unaudited condensed consolidated financial statements, following the October 1, 2025, effective date of that agreement. Credit benefit losses related to our stand ready guarantee and financial indemnification liabilities For the three and six months ended June 30, 2026, the Company recognized a credit benefit of $0.4 million and $0.7 million, respectively, compared to no benefit for the same periods in 2025. In accordance with ASC 460, the stand-ready guarantee liability is recognized on a straight-line basis over a weighted-average remaining loan maturity of three years; during the three and six months ended June 30, 2026, the Company reduced this liability, which was recognized as a benefit within operating expenses. In addition, the Company remeasured its expected liability under ASC 326 and benefited from a risk reduction on certain loans as of June 30, 2026, resulting in a reduction of the financial indemnification liability, which was also recognized as a credit benefit. Other Income Expense For The Three Months Ended June 30, 2026 2025 Change Change % Change in the fair value of deferred consideration $ - $ (40,960 ) $ 40,960 (100.0 )% Interest expense (2,290 ) (115,341 ) 113,051 (98.0 )% Interest income 23,448 - 23,448 100.0 % Loss on sale of investment (340,408 ) - (340,408 ) 100.0 % Issuance cost from the sale of the Class A Common Stock (182,229 ) - (182,229 ) 100.0 % Change in fair value of warrant liabilities 14,598 138,158 (123,560 ) (89.4 )% Total Other (Expense) Income $ (486,881 ) $ (18,143 ) $ (468,738 ) (2,583.6 )% For The Six Months Ended June 30, 2026 2025 Change Change % Change in the fair value of deferred consideration $ - $ 120,040 $ (120,040 ) (100.0 )% Interest expense (6,870 ) (228,127 ) 221,257 (97.0 )% Interest income 23,448 - 23,448 100.0 % Loss on sale of investment (340,408 ) - (340,408 ) 100.0 % Issuance cost from the sale of the Class A Common Stock (210,109 ) - (210,109 ) 100.0 % Change in fair value of warrant liabilities 31,197 1,254,240 (1,223,043 ) (97.5 )% Total Other (Expense) Income $ (502,742 ) $ 1,146,153 $ (1,648,895 ) (143.9 )% 11 Total other (expense) income For the three months ended June 30, 2026, total other income (expense) was $(0.5) million, compared to $(0.02) million for the three months ended June 30, 2025, a decline of $0.5 million. The decline was primarily attributable to issuance costs of $0.3 million and $0.2 million recognized on the share settlements, together with a $0.1 million decrease in the gain recognized on the change in fair value of the warrant liability. For the six months ended June 30, 2026, total other income (expense) was $(0.5) million, compared to total other income of $1.1 million for the six months ended June 30, 2025, a decline of $1.6 million. The decline was primarily attributable to a $1.2 million decrease in the gain recognized on the change in fair value of the warrant liability, together with issuance costs of $0.3 million and $0.2 million recognized on the share settlements, respectively, and the absence of a $0.1 million gain on the change in fair value of deferred consideration recognized in the prior-year period. These items were partially offset by a $0.2 million decrease in interest expense. Change in Fair Value of Deferred Consideration For the three months ended June 30, 2026, the Company recognized no change in the fair value of deferred consideration, compared to a loss of $0.04 million for the three months ended June 30, 2025. For the six months ended June 30, 2026, the Company recognized no change in the fair value of deferred consideration, compared to a gain of $0.1 million for the six months ended June 30, 2025. The liability was fully extinguished in October 2025 upon settlement of the third-anniversary payment obligation, and accordingly no further changes in fair value were recognized during 2026. The gain recognized for the six months ended June 30, 2025 primarily resulted from a decline in the Company’s stock price during that period, which reduced the fair value of the obligation prior to its settlement. Interest Expense The Company had no secured debt outstanding as of and during the six-month period ended June 30, 2026. Interest expense for the three and six months ended June 30, 2026, related entirely to the financing of an insurance policy, a routine, unsecured financing arrangement. By contrast, interest expense for the three and six months ended June 30, 2025, was attributable to the Senior Secured Promissory Note to PCCU (the “PCCU Note”), which the Company repaid in full prior to the current period. For the three months ended June 30, 2026, interest expense was less than $0.1 million, compared to $0.1 million for the three months ended June 30, 2025, a decrease of $0.1 million, or 98.0%. For the six months ended June 30, 2026, interest expense was less than $0.1 million, compared to $0.2 million for the six months ended June 30, 2025, a decrease of $0.2 million, or 97.0%. Interest Income For the three and six months ended June 30, 2026, the Company recognized interest income of less than $0.1 million, compared to no interest income for the same periods in 2025. Interest income relates to earnings on available cash held in an interest-bearing, cash-equivalent money market account. Loss on Sale of Investment The Company received the ADTX preferred shares in 2025 in connection with the restructuring of certain of its Series B Preferred Stock and associated warrants, and not as part of any investment strategy in the biotechnology sector. At the time of receipt, the Company anticipated recovering at least $1.5 million from the eventual sale of these shares. However, ADTX was subsequently delisted on June 23, 2026, prior to the Company’s ability to liquidate the shares, which adversely affected the value realized on disposition. 12 For the three and six months ended June 30, 2026, the Company recognized a loss of $0.3 million on the sale of its investment in preferred securities of ADTX, compared to no such loss for the same periods in 2025. During the six months ended June 30, 2026, ADTX redeemed 23 shares, and the Company liquidated its remaining 1,434 shares of ADTX preferred stock through a combination of open-market and privately negotiated transactions, generating proceeds of approximately $1.1 million, of which approximately $0.5 million remained receivable as of June 30, 2026, and is included in other current assets in the condensed unaudited consolidated balance sheet as of June 30, 2026. The liquidation of the 1,434 shares occurred during the three months ended June 30, 2026 and gave rise to the loss recognized in both periods. Issuance costs For the three months ended June 30, 2026, issuance costs from the sale of ELOC were $0.2 million. There were no issuance costs related to the same period in 2025. For the six months ended June 30, 2026, issuance costs were $0.2 million. Again, there were no issuance costs related to the same period in 2025. Issuance costs represent the difference between the stock price on the trading date and the settlement date, multiplied by the number of shares issued. Change in Fair Value of Warrant Liabilities For the three months ended June 30, 2026, the Company recognized a gain of less than $0.1 million from changes in the fair value of warrant liabilities, compared to a gain of $0.1 million for the three months ended June 30, 2025, a decrease of $0.1 million, or 89.4%. For the six months ended June 30, 2026, the Company recognized a gain of less than $0.1 million from changes in the fair value of warrant liabilities, compared to a gain of $1.3 million for the six months ended June 30, 2025, a decrease of $1.2 million, or 97.5%. The year-over-year decrease was due to the changes in the Company’s stock price during each period. As of June 30, 2026, all outstanding warrants were out of the money. Financial Condition Cash and cash equivalents Cash and cash equivalents were $5.7 million as of June 30, 2026, and $6.8 million as of December 31, 2025. Cash flows For the six months ended June 30, 2026, the Company used $2.8 million of cash in operating activities, compared to $1.8 million used during the same period in 2025. The increase in cash used was primarily driven by a higher net loss, partially offset by favorable changes in operating assets and liabilities and non-cash adjustments, including a $0.7 million credit benefit and a $0.3 million loss on the sale of investment securities. Investing activities provided $0.7 million of cash for the six months ended June 30, 2026, primarily from proceeds on the sale of the Company’s investment in preferred securities. Financing activities provided $1.1 million of cash for the six months ended June 30, 2026, from proceeds under the Company’s ELOC, compared to $0.3 million of cash used during the same period in 2025, primarily to repay the PCCU Note. 13 Liquidity Liquidity refers to our ability to meet anticipated cash demands, including funding operations, servicing contractual obligations, and covering other routine business expenditures. Our primary cash outflows include operating costs and general business expenditures. The main source of our liquidity continues to be cash inflows generated from operational performance. As of June 30, 2026, we do not have significant capital investment commitments. As of June 30, 2026, the Company had no secured debt, cash and cash equivalents of $5.7 million, working capital of $4.7 million, and total stockholders’ equity of $6.1 million, which exceeds the minimum Nasdaq requirements. The Company has incurred recurring losses from operations and negative cash flows from operations, including an operating loss of $2.8 million and net cash used in operating activities of $2.8 million for the six months ended June 30, 2026, and an accumulated deficit of $126.2 million as of June 30, 2026. In addition, it is reasonably possible but not probable that a material adverse effect may result from the litigation matter as discussed in Note 16, Commitments and Contingencies. These conditions, considered in the aggregate, raise substantial doubt about the Company’s ability to continue as a going concern. Management has developed and is implementing a series of measures intended to preserve liquidity and support the Company’s ability to meet its obligations during the look-forward period: ● Strengthened Revenue Profile: The Second Amended Commercial Alliance Agreement (“Second Amended CAA”) with PCCU, effective October 1, 2025, increased the Company’s share of loan program income from approximately 35% to up to 65% of the loan program income generated by PCCU’s CRB loan portfolio, improving the recurring revenue profile of the Company’s core business on a prospective basis. For the six months ended June 30, 2026, this change increased loan program income by approximately $0.6 million comparatively. In addition, t he asset hosting fee structure transitioned from a flat rate to a tiered marginal rate schedule based on average daily deposit balances, with rates ranging from 0.50% on the first $25 million to 1.25% on balances above $125 million, resulting in estimated annual savings of approximately $0.3 million compared to the rates contained in the First Amended CAA. The Company is also exploring strategic relationships with additional financial institutions. ● Access to Additional Capital: On September 17, 2025, the Company entered into the Equity Line of Credit (“ELOC”) with an institutional investor (the “ELOC Investor”), under which the Company may, at its sole discretion and subject to customary conditions, sell up to $150.0 million of newly issued shares of Common Stock to the investor party thereto. The ELOC expires on September 17, 2028. For the six months ended June 30, 2026, the Company raised $1.1 million from the use of the ELOC. The Company’s continued ability to access the ELOC is subject to a number of conditions, including the absence of any Material Adverse Effect (as defined on page F-27 in subsection “Equity Line of Credit and Related Series B Redemption Obligation”), and there can be no assurance that the Company will be able to draw the full amount of the commitment. See Note 15, Stockholders’ Equity . There is no assurance that the Company can use the ELOC due to the current stock price. ● Expense Management: The Company is making strategic investments in marketing, lending and system development. Management has identified specific actionable cost reductions that are within its direct operational control and that it would implement should operating conditions deteriorate below base-case expectations, including pausing or restructuring said strategic investments. ● Cash Flow Monitoring: Management maintains a 52-week rolling cash flow projection that tracks anticipated expenses, revenues, and ending cash balances against budget. Cash positions are reviewed on a bi-weekly basis to ensure the Company maintains adequate liquidity to fund operations. Notwithstanding the measures described above, the Company continues to incur operating losses and negative cash flows from operations, and the Company’s ability to access the ELOC and to execute on its expense-management plans involves elements outside of management’s sole control. Accordingly, management has concluded that management’s plans, considered in the aggregate, do not alleviate the substantial doubt about the Company’s ability to continue as a going concern for a period of at least twelve months from the date these unaudited condensed consolidated financial statements are issued. The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets, or the amounts and classification of liabilities that might result from the outcome of this uncertainty. Litigation On October 17, 2024, the Company filed a complaint in the Denver County, Colorado District Court (the “District Court”), captioned SHF Holdings, Inc. v. Daniel Roda, Gregory W. Ellis, and James R. Carroll , Case No. 2024CV33187. The lawsuit arises from a dispute over the terms of the Company’s October 2022 acquisition of Rockview Digital Solutions, Inc. d/b/a Abaca (“Abaca”) pursuant to a merger agreement (the “Merger Agreement”) that was subsequently amended in November 2022 and in October 2023 (the “Second Amendment”). The Second Amendment restructured certain merger consideration, including introducing warrants and modifying payment timing. The defendants contend the Second Amendment is invalid under Delaware law and seek to have it set aside, which would reinstate the original payment terms and potentially increase the Company’s obligations. The Company maintains that the Second Amendment was validly executed and is binding. On November 21, 2024, at the Company’s request, the disputed merger payment of $3.0 million was deposited into the Denver County, Colorado District Court’s registry pending resolution of the dispute. This amount has been reflected in the Company’s unaudited condensed consolidated balance sheet. 14 On December 19, 2024, the defendants filed an answer and counterclaims against the Company. On April 18, 2025, the District Court issued an order denying the Company’s motion to dismiss most of the counterclaims, but the District Court did dismiss claims against the Company’s Chairman, Fred Niehaus, with prejudice. The District Court also clarified that the Delaware statutes cited by the defendants govern pre-closing amendments and do not authorize post-merger amendments altering consideration, a finding that is consistent with the Company’s legal position. On April 23, 2026, the District Court issued an omnibus order on cross-motions for summary judgment in the matter. The Court denied the Company’s motion for summary judgment in its entirety. The Court granted the counterclaim plaintiffs’ cross-motion in part, primarily ruling that the Second Amendment to the Merger Agreement is void ab initio under Section 251(d) of the Delaware General Corporation Law, and because of that ruling, that the Company breached the original Merger Agreement with respect to the first anniversary parent shares. Damages on this counterclaim are set for trial on August 10-11, 2026. The Court also denied both parties’ motions on the counterclaim concerning the second anniversary cash consideration payment of $3.0 million and denied the counterclaim plaintiffs’ motion on the Company’s declaratory judgment claim; those claims are also set for trial on August 10–11, 2026. The Court’s order is not final, it is an appealable order under C.R.C.P. 54(b). The $3.0 million previously deposited into the Court’s registry in November 2024 remains reflected in the Company’s condensed consolidated financial statements. The Company intends to continue defending its positions vigorously. The range of loss is $0 to $7.8 million. An adverse resolution could have a material adverse effect on the Company’s financial position, results of operations, or cash flows. In addition, the Company may evaluate the possibility of a negotiated resolution of the dispute. In the event of a negotiated resolution, the Company’s ability to fund any payments owed in cash may be materially constrained by the terms of the previously disclosed ELOC, and the Company’s Series B Convertible Preferred Stock. Litigation is inherently uncertain, and there can be no assurance that any negotiated resolution will be reached or that the terms of any such resolution are favorable to the Company. See Part II, Item 1A. “ Risk Factors-Recent developments in shareholder litigation against us on certain counterclaims could result in a material adverse effect on our financial position, results of operations, and cash flows.” Critical Accounting Estimates As of June 30, 2026, there were no significant changes in the application or the nature of accounting estimates that are considered critical in nature from those presented in our Annual Report on Form 10-K. Emerging Growth Company Status We are an emerging growth company (“EGC”) as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). As such, we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies,” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (“SOX”), reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. In addition, Section 107 of the JOBS Act also provides that an EGC can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act, for complying with new or revised accounting standards. In other words, an EGC can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We intend to take advantage of the benefits of this extended transition period, for as long as it is available. We will remain an EGC until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of the date of the first sale of our common equity securities pursuant to an effective registration statement under the Securities Act, which is December 31, 2026, and (b) in which we have total annual gross revenue of at least $1.07 billion, (2) the date on which we are deemed to be a large accelerated filer, which means the market value of our Common Stock that is held by non-affiliates exceeds $700 million as of the last business day of our most recently completed second fiscal quarter, and (3) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year period. References herein to “emerging growth company” have the meaning provided in the JOBS Act. The Company will cease to be an EGC on December 31, 2026. Smaller Reporting Company We are a “smaller reporting company” as defined in Item 10(f)(1) of Regulation S-K, which allows us to take advantage of certain exemptions from disclosure requirements including exemption from compliance with the auditor attestation requirements of Section 404. We will remain a smaller reporting company until the last day of the fiscal year in which (i) the market value of the shares of our Common Stock held by non-affiliates exceeds $250.0 million as of the prior June 30, and (ii) our annual revenue exceeded $100.0 million during such completed fiscal year or the market value of the shares of our Common Stock held by non-affiliates exceeds $700.0 million as of the prior June 30. To the extent we take advantage of such reduced disclosure obligations, it may also make comparison of our financial statement with other public companies difficult or impossible. Internal Control Over Financial Reporting In connection with our management’s assessment of internal control over financial reporting as of and for the six months ended June 30, 2026, the Company has identified material weaknesses within our internal controls over financial reporting. Refer to Part I, Item 4 of this document for additional details. For the six months ended June 30, 2026, the material weakness related to the completeness and accuracy of account activity fee income has been remediated, however sufficient time has not elapsed to conclude that the related controls are operating effectively. Related Party Relationships PCCU is a related party because it held approximately 8.8% of the Company’s Common Stock as of June 30, 2026, holds 49.2% of the Series B Preferred Stock and 43.9% of the Series B Warrants as of the date hereof, and serves as the federally regulated credit union through which the Company’s CRB clients hold their deposit accounts and obtain loans. Because PCCU holds the majority of the Company’s client deposits and has the ability to significantly influence the Company’s management and operating policies, all transactions and arrangements between the Company and PCCU are disclosed as related party transactions in accordance with ASC 850 and SEC Regulation S-X. However, as of May 21, 2025, PCCU no longer has contractual rights to appoint members to the Board of Directors. 15 Item 3. Quantitative and Qualitative Disclosures About Market Risk. The Company is a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and is not required to provide the information otherwise required with respect to market risk. Item 4. Controls and Procedures. Evaluation of Disclosure Controls and Procedures Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer / Chief Financial Officer and our Principal Accounting Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon their evaluation, our Chief Executive Officer / Chief Financial Officer and Principal Accounting Officer concluded that, solely due to the below-mentioned material weaknesses, the Company’s disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were not effective as of June 30, 2026. Material Weaknesses A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. As disclosed in Item 9A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, management identified, during the fourth quarter of 2025, a material weakness in internal control over financial reporting related to the Company’s loan documentation and expected credit loss estimation process (the “Loan Documentation Material Weakness”). This material weakness arose in connection with the Company’s initial recognition, under the Second Amended CAA effective October 1, 2025, of a stand-ready guarantee liability at fair value under ASC 460 and an expected credit loss liability under ASC 326-20. Both measurements rely on underlying CRB loan documentation maintained as part of the Company’s credit administration responsibilities under the Second Amended CAA. In connection with the year-end audit, certain loan documentation used in connection with these measurements was identified as out of date or inconsistent with the terms of the underlying loans. The Loan Documentation Material Weakness remained outstanding as of June 30, 2026. While the Company’s valuation conclusions with respect to the stand-ready guarantee liability and the expected credit loss liability were determined to be fairly stated as of June 30, 2026, the absence of a formalized loan documentation review and maintenance process represents a control deficiency that, if not remediated, could result in a material misstatement of the Company’s indemnification liability under ASC 460 or its expected credit loss liability under ASC 326-20 in future periods. 16 Remediation of Loan Documentation Material Weakness Management has taken substantive steps to remediate the Loan Documentation Material Weakness. These steps have included developing a formal remediation plan, discussing and confirming the design of that plan with the Company’s independent registered public accounting firm, implementing the remediation plan which included the development of new checklists, procedures and the restructuring of the relevant department. Management is currently evaluating the operating effectiveness of the controls implemented under the plan. A material weakness is not considered remediated until management concludes, through testing, that the applicable controls have operated effectively for a sufficient period of time. Management currently anticipates that the Loan Documentation Material Weakness will be considered remediated during the fourth quarter of 2026, provided that a sufficient volume of loan activity occurs during that period to allow management to evidence the operating effectiveness of the remediated controls. There can be no assurance that the material weakness will be remediated within this anticipated timeframe, or at all, particularly if loan origination or renewal volume during the relevant period is insufficient to support management’s testing of the remediated controls. A failure to maintain effective internal controls over financial reporting could result in errors in our financial statements that could require us to restate past financial statements, cause us to fail to meet our reporting obligations, and cause investors to lose confidence in our reported financial information, all of which could materially and adversely affect the Company. Status of Previously Remediated Material Weakness As also disclosed in Item 9A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, the previously identified material weakness related to the completeness and accuracy of account activity fee income earned on CRB deposits held at PCCU has been remediated. As of June 30, 2026, sufficient time has not yet elapsed to enable management to conclude that the related controls are operating effectively. Management will continue to monitor the operating effectiveness of these controls during 2026. Changes in Internal Control Over Financial Reporting Other than the remediation activities described above with respect to the Loan Documentation Material Weakness, there were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the three and six months ended June 30, 2026, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. 17 PART II - OTHER INFORMATION Item 1. Legal Proceedings From time to time, we may be subject to various other legal proceedings and claims that are routine and incidental to our business. Although some of the legal proceedings set forth herein may result in adverse decisions or settlements, management believes that the final disposition of such matters will not have a material adverse effect on our business, financial position, results of operations or cash flows. For additional information regarding certain legal proceedings, see Note 16 – Commitments and Contingencies to the Company’s consolidated financial statements in this Form 10-Q. Item 1A. Risk Factors A new Nasdaq rule will delist companies whose market capitalization falls below $5 million for 30 or more consecutive trading days. On July 22, 2026, the SEC approved a proposed Nasdaq rule (originally filed with the SEC on January 13, 2026) that would require Nasdaq-listed companies to maintain a minimum market value of listed securities (“MVLS”) of at least $5 million. As approved, the rule provides that if a company fails to maintain this minimum for a period of thirty consecutive business days, it will be immediately subject to suspension and delisting, without any cure or compliance period. Subsequent to the SEC’s approval, on July 29, 2026, the SEC notified Nasdaq that it had received notices of intention to petition for review of the July 22, 2026 approval order and that, as a result, the order is stayed until the SEC orders otherwise. The new MVLS requirement is therefore not currently in effect, and we cannot predict whether or when the stay will be lifted, whether the rule will be modified or vacated as a result of the pending review, or when any such rule would become effective if approved. If the stay is lifted and the rule becomes effective, and if we fail to satisfy its requirements, Nasdaq would commence delisting procedures against the Company. In that event, our Common Stock would likely then trade only in the over-the-counter market and the market liquidity of our Common Stock could be adversely affected and its market price could decrease. If our Common Stock was to trade on the over-the-counter market, selling our Common Stock could be more difficult because smaller quantities of shares would likely be bought and sold, transactions could be delayed, and we could face significant material adverse consequences, including: a limited availability of market quotations for our securities; reduced liquidity with respect to our securities; a determination that our shares are a “penny stock,” which will require brokers trading in our securities to adhere to more stringent rules, possibly resulting in a reduced level of trading activity in the secondary trading market for our securities; a reduced amount of news and analyst coverage for the Company; and a decreased ability to issue additional securities or obtain additional financing in the future. These factors could result in lower prices and larger spreads in the bid and ask price for our Common Stock and would substantially impair our ability to raise additional funds and could result in a loss of institutional investor interest and fewer development opportunities for us. In the event of a delisting, we would expect to take actions to restore our compliance with the listing requirements, but we can provide no assurance that any such action taken by us would allow our Common Stock to become listed again, stabilize the market price or improve the liquidity of our Common Stock, prevent our Common Stock from dropping below the minimum market value of listed securities, or prevent future non-compliance with the listing requirements. Recent developments in shareholder litigation against us on certain counterclaims could result in a material adverse effect on our financial position, results of operations, and cash flows. As previously disclosed in a Current Report on Form 8-K filed with the SEC, on April 23, 2026 the District Court granted summary judgment against us on counterclaims relating to the validity of the Second Amendment and our payment of the first anniversary parent shares, with damages to be determined at a future hearing. The District Court’s order is not final, it is an appealable order. Additional claims, including a counterclaim concerning the $3.0 million second anniversary cash consideration payment and our declaratory judgment claim, remain set for trial on August 10 and 11, 2026. We intend to defend our positions vigorously and to pursue all available legal options, but we may not prevail at trial or on any appeal that may become available. The ultimate resolution of the litigation could result in damages, settlement payments, or other obligations that are material to us. Our ability to fund any such payment in cash may be materially constrained by the terms of the ELOC or our Series B Convertible Preferred Stock. The $3.0 million previously deposited into the District Court’s registry remains reflected in our condensed consolidated financial statements pending resolution of the related claims and is not currently available for our general operating or strategic use. An adverse outcome could have a material adverse effect on our business, financial position, results of operations, cash flows, liquidity, the trading price of our securities, and our ability to regain or maintain compliance with applicable Nasdaq listing standards. See Part I, Item 2 “Management’s Discussion and Analysis of Financial Condition and Results of Operations–Litigation” and Note 16, “Commitments and Contingencies” for additional details. Item 2. Unregistered Sales of Equity Securities and Use of Proceeds During the three months ended June 30, 2026, the Company issued 2,907,462 shares of Common Stock under the ELOC and received net proceeds of $1.0 million with an average price per share of $0.33. These issuances were made in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D promulgated thereunder. Item 3. Defaults Upon Senior Securities None. Item 4. Mine Safety Disclosures Not applicable. Item 5. Other Information None. 18 Item 6. Exhibits The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q. No. Description of Exhibit 3.1 Second Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on September 29, 2022). 3.2 Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed March 20, 2025). 3.3 Certificate of Amendment to Second Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K, filed on November 10, 2025). 3.4 Bylaws of the Company (incorporated by reference to Exhibit 3.3 to the Company’s Registration Statement on Form S-1 filed on June 2, 2021). 3.5 Certificate of Designation of Series B Preferred Stock of SHF Holdings, Inc., dated September 30, 2025 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on October 3, 2025). 3.6 Amendment to SHF Holdings, Inc. Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on November 10, 2025). 31.1* Certification of Principal Executive Officer and Principal Chief Financial Officer Pursuant to Securities and Exchange Act Rule 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 31.2* Certification of Principal Accounting Officer Pursuant to Securities and Exchange Act Rule 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 32.1** Certificate of Principal Executive Officer and Principal Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 32.2** Certificate of Principal Accounting Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 101.INS* Inline XBRL Instance Document 101.CAL* Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.SCH* Inline XBRL Taxonomy Extension Schema Document 101.DEF* Inline XBRL Taxonomy Extension Definition Linkbase Document 101.LAB* Inline XBRL Taxonomy Extension Labels Linkbase Document 101.PRE* Inline XBRL Taxonomy Extension Presentation Linkbase Document 104* Cover Page Interactive Data File (embedded within the Inline XBRL document) * Filed herewith. ** Furnished. † Pursuant to Item 601(a)(5) of Regulation S-K, schedules and similar attachments to this exhibit have been omitted because they do not contain information material to an investment or voting decision and such information is not otherwise disclosed in such exhibit. The Company will supplementally provide a copy of any omitted schedule or similar attachment to the U.S. Securities and Exchange Commission or its staff upon request. 19 SIGNATURES Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Signature Title Date /s/ Terrance E. Mendez Chief Executive Officer and Chief Financial Officer August 7, 2026 Terrance E. Mendez (Principal Executive Officer) /s/ Douglas Beck Principal Accounting Officer, Senior Vice President of Finance August 7, 2026 Douglas Beck (Principal Financial and Accounting Officer) 20